Pathogenicity |
Thymol Reduces agr-Mediated Virulence Factor Phenol-Soluble Modulin Production in Staphylococcus aureus. |
Lade H, Chung SH, Lee Y, Kumbhar BV, Joo HS, Kim YG, Yang YH, Kim JS |
Biomed Res Int |
10.1155/2022/8221622 |
2022 |
* |
Pathogenicity |
In Silico and Experimental Investigation of the Biological Potential of Some Recently Developed Carprofen Derivatives. |
Dumitrascu F, Udrea AM, Caira MR, Nuta DC, Limban C, Chifiriuc MC, Popa M, Bleotu C, Hanganu A, Dumitrescu D, Avram S |
Molecules |
10.3390/molecules27092722 |
2022 |
* |
Biotechnology |
Effects of citronellal on growth and enterotoxins production in Staphylococcus aureus ATCC 29213. |
Zhang M, Li H, Agyekumwaa AK, Yu Y, Xiao X |
Toxicon |
10.1016/j.toxicon.2022.04.016 |
2022 |
* |
Pathogenicity |
Tagetes lucida Cav. essential oil and the mixture of its main compounds are antibacterial and modulate antibiotic resistance in multi-resistant pathogenic bacteria. |
Torres-Martinez R, Moreno-Leon A, Garcia-Rodriguez YM, Hernandez-Delgado T, Delgado-Lamas G, Espinosa-Garcia FJ |
Lett Appl Microbiol |
10.1111/lam.13721 |
2022 |
* |
Phylogeny |
Isolation and Characterization of Halophilic Kocuria salsicia Strains from Cheese Brine. |
Youn HY, Seo KH |
Food Sci Anim Resour |
10.5851/kosfa.2022.e1 |
2022 |
* |
Pathogenicity |
Investigating antimicrobial features and drug interactions of sedoanalgesics in intensive care unit: an experimental study. |
Unlu O, Bingul ES, Kesici S, Demirci M |
ADMET DMPK |
10.5599/admet.1042 |
2021 |
* |
Pathogenicity |
Loaded n-Hydroxyapatite/SSG 3D Scaffolds as a Drug Delivery System of Nigella sativa Fractions for the Management of Local Antibacterial Infections. |
Dalli M, El Guerraf A, Azizi SE, Benataya K, Azghar A, Mi-Kyung J, Maleb A, Bonglee K, Gseyra N |
Nanomaterials (Basel) |
10.3390/nano12050856 |
2022 |
* |
Pathogenicity |
Synthesis, Antimicrobial Evaluation, and Molecular Modeling Studies of New Thiosemicarbazide-Triazole Hybrid Derivatives of (S)-Naproxen. |
Han MI, Ince U, Gunduz MG, Kucukguzel SG |
Chem Biodivers |
10.1002/cbdv.202100900 |
2022 |
* |
Pathogenicity |
Antibacterial activity and mechanism of essential oils in combination with medium-chain fatty acids against predominant bovine mastitis pathogens. |
Rani S, Verma S, Singh H, Ram C |
Lett Appl Microbiol |
10.1111/lam.13675 |
2022 |
* |
Pathogenicity |
Contribution to the Evaluation of Physicochemical Properties, Total Phenolic Content, Antioxidant Potential, and Antimicrobial Activity of Vinegar Commercialized in Morocco. |
Kara M, Assouguem A, Fadili ME, Benmessaoud S, Alshawwa SZ, Kamaly OA, Saghrouchni H, Zerhouni AR, Bahhou J |
Molecules |
10.3390/molecules27030770 |
2022 |
* |
Pathogenicity |
Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure. |
Gaillard T, Dupieux-Chabert C, Butin M, Dumitrescu O, Naceur O, Bouveyron C, Martra A, Bes M, Tristan A, Vandenesch F, Lina G, Laurent F, Rasigade JP |
J Antimicrob Chemother |
10.1093/jac/dkab488 |
2022 |
* |
Pathogenicity |
Comparative Study of Antimicrobial, Anti-Inflammatory, and Antioxidant Activities of Different Parts from Pterocarpus Santalinoides l'Her. Ex. DC (Fabaceae). |
Ayena AC, Anani K, Dosseh K, Agbonon A, Gbeassor M |
Evid Based Complement Alternat Med |
10.1155/2021/8938534 |
2021 |
* |
Pathogenicity |
Towards Property Profiling: SYNTHESIS and SAR Probing of New Tetracyclic Diazaphenothiazine Analogues. |
Empel A, Bak A, Kozik V, Latocha M, Cizek A, Jampilek J, Suwinska K, Sochanik A, Zieba A |
Int J Mol Sci |
10.3390/ijms222312826 |
2021 |
* |
Pathogenicity |
A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking. |
Zhang Z, Zhang ZS, Wang X, Xi GL, Jin Z, Tang YZ |
J Enzyme Inhib Med Chem |
10.1080/14756366.2021.1977931 |
2021 |
* |
Enzymology |
Penicisteckins A-F, Isochroman-Derived Atropisomeric Dimers from Penicillium steckii HNNU-5B18. |
Wu XZ, Huang WJ, Liu W, Mandi A, Zhang Q, Zhang L, Zhang W, Kurtan T, Yuan CS, Zhang C |
J Nat Prod |
10.1021/acs.jnatprod.1c00787 |
2021 |
* |
Pathogenicity |
Design, Synthesis, and Antibacterial Evaluation of Novel Ocotillol Derivatives and Their Synergistic Effects with Conventional Antibiotics. |
Zhang D, Cao Y, Wang K, Shi Z, Wang R, Meng Q, Bi Y |
Molecules |
10.3390/molecules26195969 |
2021 |
* |
Pathogenicity |
Chalcogenide nanoparticles and organic photosensitizers for synergetic antimicrobial photodynamic therapy. |
Garin C, Alejo T, Perez-Laguna V, Prieto M, Mendoza G, Arruebo M, Sebastian V, Rezusta A |
J Mater Chem B |
10.1039/d1tb00972a |
2021 |
* |
Pathogenicity |
Aloe-Emodin-Mediated Photodynamic Therapy Attenuates Sepsis-Associated Toxins in Selected Gram-Positive Bacteria In Vitro. |
Otieno W, Liu C, Ji Y |
J Microbiol Biotechnol |
10.4014/jmb.2105.05024 |
2021 |
* |
Biotechnology |
Antimicrobial Effects of Novel H2O2-Ag+ Complex on Membrane Damage to Staphylococcus aureus, Escherichia coli O157:H7, and Salmonella Typhimurium. |
Han B, Han X, Ren M, You Y, Zhan J, Huang W |
J Food Prot |
10.4315/JFP-21-087 |
2022 |
* |
Pathogenicity |
Rational Design of Dipicolylamine-Containing Carbazole Amphiphiles Combined with Zn(2+) as Potent Broad-Spectrum Antibacterial Agents with a Membrane-Disruptive Mechanism. |
Liu J, Li H, Li H, Fang S, Shi J, Chen Y, Zhong R, Liu S, Lin S |
J Med Chem |
10.1021/acs.jmedchem.1c00858 |
2021 |
* |
Pathogenicity |
Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo. |
Li B, Zhang Z, Zhang JF, Liu J, Zuo XY, Chen F, Zhang GY, Fang HQ, Jin Z, Tang YZ |
Eur J Med Chem |
10.1016/j.ejmech.2021.113624 |
2021 |
* |
Phylogeny |
Study of the impact of cultivation conditions and peg surface modification on the in vitro biofilm formation of Staphylococcus aureus and Staphylococcus epidermidis in a system analogous to the Calgary biofilm device. |
Diepoltova A, Konecna K, Jandourek O, Nachtigal P |
J Med Microbiol |
10.1099/jmm.0.001371 |
2021 |
* |
Pathogenicity |
Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome. |
Huang SY, Wang X, Shen DY, Chen F, Zhang GY, Zhang Z, Li K, Jin Z, Du D, Tang YZ |
Bioorg Med Chem |
10.1016/j.bmc.2021.116138 |
2021 |
* |
Pathogenicity |
Effect of sub-lethal doses of nisin on Staphylococcus aureus toxin production and biofilm formation. |
Shivaee A, Rajabi S, Farahani HE, Imani Fooladi AA |
Toxicon |
10.1016/j.toxicon.2021.03.018 |
2021 |
* |
Pathogenicity |
Composition of Essential Oils from Roots and Aerial Parts of Carpesium cernuum and Their Antibacterial and Cytotoxic Activities. |
Wajs-Bonikowska A, Malarz J, Szoka L, Kwiatkowski P, Stojakowska A |
Molecules |
10.3390/molecules26071883 |
2021 |
* |
Enzymology |
Moringa oleifera leaves: could solvent and extraction method affect phenolic composition and bioactivities? |
Bennour N, Mighri H, Bouhamda T, Mabrouk M, Apohan E, Yesilada O, Kucukbay H, Akrout A |
Prep Biochem Biotechnol |
10.1080/10826068.2021.1891550 |
2021 |
* |
Pathogenicity |
Therapeutic Effects of Newly Synthesized Boron Compounds (BGM and BGD) on Hepatocellular Carcinoma. |
Gunduz MK, Bolat M, Kaymak G, Berikten D, Kose DA |
Biol Trace Elem Res |
10.1007/s12011-021-02647-9 |
2021 |
* |
Pathogenicity |
Development and characterization of lyophilized cefpodoxime proxetil-Pluronic((R)) F127/polyvinylpyrrolidone K30 solid dispersions with improved dissolution and enhanced antibacterial activity. |
Yurtdas-Kirimlioglu G |
Pharm Dev Technol |
10.1080/10837450.2021.1889584 |
2021 |
* |
Pathogenicity |
Ultrastructural changes in methicillin-resistant Staphylococcus aureus (MRSA) induced by a novel cyclic peptide ASP-1 from Bacillus subtilis: A scanning electron microscopy (SEM) study. |
Deshmukh R, Chalasani AG, Chattopadhyay D, Roy U |
Rev Argent Microbiol |
10.1016/j.ram.2020.11.006 |
2021 |
* |
Enzymology |
Antibacterial Prenylated p-Hydroxybenzoic Acid Derivatives from Oberonia myosurus and Identification of Putative Prenyltransferases. |
Ren FC, Liu L, Lv YF, Bai X, Kang QJ, Hu XJ, Zhuang HD, Yang L, Hu JM, Zhou J |
J Nat Prod |
10.1021/acs.jnatprod.0c01101 |
2021 |
* |
Metabolism |
Extracellular myco-synthesis of nano-silver using the fermentable yeasts Pichia kudriavzeviiHA-NY2 and Saccharomyces uvarumHA-NY3, and their effective biomedical applications. |
Ammar HA, El Aty AAA, El Awdan SA |
Bioprocess Biosyst Eng |
10.1007/s00449-020-02494-3 |
2021 |
* |
Pathogenicity |
The sponges Hymeniacidon perlevis and Halichondria panicea are reservoirs of antibiotic-producing bacteria against multi-drug resistant Staphylococcus aureus. |
Rodriguez Jimenez A, Dechamps E, Giaux A, Goetghebuer L, Bauwens M, Willenz P, Flahaut S, Laport MS, George IF |
J Appl Microbiol |
10.1111/jam.14999 |
2021 |
* |
Pathogenicity |
Evaluation of Antibacterial Activity of Three Quaternary Ammonium Disinfectants on Different Germs Isolated from the Hospital Environment. |
Ramzi A, Oumokhtar B, Ez Zoubi Y, Filali Mouatassem T, Benboubker M, El Ouali Lalami A |
Biomed Res Int |
10.1155/2020/6509740 |
2020 |
* |
Metabolism |
An in vitro selective inhibitory effect of silver(i) aminoacidates against bacteria and intestinal cell lines and elucidation of the mechanism of action by means of DNA binding properties, DNA cleavage and cell cycle arrest. |
Rendosova M, Gyepes R, Maruscakova IC, Mudronova D, Sabolova D, Kello M, Vilkova M, Almasi M, Huntosova V, Zemek O, Vargova Z |
Dalton Trans |
10.1039/d0dt03332d |
2020 |
* |
Enzymology |
Structurally diverse polyketides and phenylspirodrimanes from the soft coral-associated fungus Stachybotrys chartarum SCSIO41201. |
Yang B, Long J, Pang X, Lin X, Liao S, Wang J, Zhou X, Li Y, Liu Y |
J Antibiot (Tokyo) |
10.1038/s41429-020-00386-y |
2020 |
* |
Pathogenicity |
Development and validation of a new microplate assay that utilises optical density to quantify the antibacterial activity of honeys including Jarrah, Marri and Manuka. |
Green KJ, Dods K, Hammer KA |
PLoS One |
10.1371/journal.pone.0243246 |
2020 |
* |
Pathogenicity |
Enhancing Drug Efficacy against Mastitis Pathogens-An In Vitro Pilot Study in Staphylococcus aureus and Staphylococcus epidermidis. |
Rajamanickam K, Yang J, Chidambaram SB, Sakharkar MK |
Animals (Basel) |
10.3390/ani10112117 |
2020 |
* |
Pathogenicity |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis. |
Malasala S, Ahmad MN, Akunuri R, Shukla M, Kaul G, Dasgupta A, Madhavi YV, Chopra S, Nanduri S |
Eur J Med Chem |
10.1016/j.ejmech.2020.112996 |
2020 |
* |
Pathogenicity |
Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker. |
Zhang GY, Zhang Z, Li K, Liu J, Li B, Jin Z, Liu YH, Tang YZ |
Bioorg Chem |
10.1016/j.bioorg.2020.104398 |
2020 |
* |
Pathogenicity |
Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies. |
Cavalluzzi MM, Budriesi R, De Salvia MA, Quintieri L, Piarulli M, Milani G, Gualdani R, Micucci M, Corazza I, Rosato A, Viale M, Caputo L, Franchini C, Lentini G |
Pharmacol Rep |
10.1007/s43440-020-00167-2 |
2020 |
* |
Biotechnology |
Antibacterial effects of hydrogen peroxide and caprylic acid on selected foodborne bacteria. |
Vyrostkova J, Pipova M, Semjon B, Jevinova P, Regecova I, Malova J |
Pol J Vet Sci |
10.24425/pjvs.2020.134689 |
2020 |
* |
Biotechnology |
Production of 3-desmethyl protostreptovaricin I from the genetically engineered Streptomyces spectabilis CCTCC M2017417. |
Liu Y, Cui X, Li Z, Chen X, Zeng G, Sun Y |
J Asian Nat Prod Res |
10.1080/10286020.2020.1816976 |
2020 |
* |
Pathogenicity |
Type I collagen hydrogels as a delivery matrix for royal jelly derived extracellular vesicles. |
Ramirez OJ, Alvarez S, Contreras-Kallens P, Barrera NP, Aguayo S, Schuh CMAP |
Drug Deliv |
10.1080/10717544.2020.1818880 |
2020 |
* |
Enzymology |
Development of Highly Potent Carbazole Amphiphiles as Membrane-Targeting Antimicrobials for Treating Gram-Positive Bacterial Infections. |
Lin S, Liu J, Li H, Liu Y, Chen Y, Luo J, Liu S |
J Med Chem |
10.1021/acs.jmedchem.0c00433 |
2020 |
* |
Enzymology |
Azacoccones F-H, new flavipin-derived alkaloids from an endophytic fungus Epicoccum nigrum MK214079. |
Harwoko H, Lee J, Hartmann R, Mandi A, Kurtan T, Muller WEG, Feldbrugge M, Kalscheuer R, Ancheeva E, Daletos G, Frank M, Liu Z, Proksch P |
Fitoterapia |
10.1016/j.fitote.2020.104698 |
2020 |
* |
Pathogenicity |
Stability studies with tigecycline in bacterial growth medium and impact of stabilizing agents. |
Amann LF, Vicente ER, Rathke M, Broeker A, Riedner M, Wicha SG |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-020-03970-0 |
2020 |
* |
Phylogeny |
In Vitro Antimicrobial and Antiproliferative Activities of the Root Bark Extract and Isolated Chemical Constituents of Zanthoxylum paracanthum Kokwaro (Rutaceae). |
Kaigongi MM, Lukhoba CW, Yaouba S, Makunga NP, Githiomi J, Yenesew A |
Plants (Basel) |
10.3390/plants9070920 |
2020 |
* |
Phylogeny |
Molecular Mechanisms and Epidemiology of Fosfomycin Resistance in Staphylococcus aureus Isolated From Patients at a Teaching Hospital in China. |
Xu W, Chen T, Wang H, Zeng W, Wu Q, Yu K, Xu Y, Zhang X, Zhou T |
Front Microbiol |
10.3389/fmicb.2020.01290 |
2020 |
* |
Pathogenicity |
Insight into antimicrobial activity of substituted phenylcarbamoyloxypiperazinylpropanols. |
Pospisilova S, Malik I, Curillova J, Michnova H, Cerna L, Padrtova T, Hosek J, Pecher D, Cizek A, Jampilek J |
Bioorg Chem |
10.1016/j.bioorg.2020.104060 |
2020 |
* |
Pathogenicity |
Design, synthesis, and evaluation of amphiphilic sofalcone derivatives as potent Gram-positive antibacterial agents. |
Lin S, Chen Y, Li H, Liu J, Liu S |
Eur J Med Chem |
10.1016/j.ejmech.2020.112596 |
2020 |
* |
Pathogenicity |
Synthesis of Iron(II)-N-Heterocyclic Carbene Complexes: Paving the Way for a New Class of Antibiotics. |
Vinagreiro CS, Lopes R, Royo B, Da Silva GJ, Pereira MM |
Molecules |
10.3390/molecules25122917 |
2020 |
* |
Pathogenicity |
Activity-directed expansion of a series of antibacterial agents. |
Leggott A, Clarke JE, Chow S, Warriner SL, O'Neill AJ, Nelson A |
Chem Commun (Camb) |
10.1039/d0cc02361b |
2020 |
* |
Metabolism |
Biogenic iron-silver nanoparticles inhibit bacterial biofilm formation due to Ag(+) release as determined by a novel phycoerythrin-based assay. |
Cusimano MG, Ardizzone F, Nasillo G, Gallo M, Sfriso A, Martino-Chillura D, Schillaci D, Baldi F, Gallo G |
Appl Microbiol Biotechnol |
10.1007/s00253-020-10686-w |
2020 |
* |
Pathogenicity |
Antimicrobial and Anti-Inflammatory Activity of Some Lathyrus L. (Fabaceae) Species Growing in Turkey. |
Heydari H, Saltan Iscan G, Eryilmaz M, Bahadir Acikara O, Yilmaz Sarialtin S, Tekin M, Coban T |
Turk J Pharm Sci |
10.4274/tjps.galenos.2018.86719 |
2019 |
* |
Pathogenicity |
Chemical composition, antimicrobial and cytotoxic activities of essential oils from Schinus polygamus (Cav.) cabrera leaf and bark grown in Egypt. |
El-Nashar HAS, Mostafa NM, El-Badry MA, Eldahshan OA, Singab ANB |
Nat Prod Res |
10.1080/14786419.2020.1765343 |
2020 |
* |
Metabolism |
A eukaryotic expression strategy for producing the novel antimicrobial peptide PRW4. |
Zhan N, Wang T, Zhang L, Shan A |
Braz J Microbiol |
10.1007/s42770-020-00291-4 |
2020 |
* |
Pathogenicity |
Development and Characterization of Polymeric Peptides for Antibody Tagging of Bacterial Targets. |
Climacosa FMM, King RAN, Santos BMM, Caoili SEC |
Protein Pept Lett |
10.2174/0929866527666200427212940 |
2020 |
* |
Pathogenicity |
High Fluence Increases the Antibacterial Efficacy of PACK Cross-Linking. |
Kling S, Hufschmid FS, Torres-Netto EA, Randleman JB, Willcox M, Zbinden R, Hafezi F |
Cornea |
10.1097/ICO.0000000000002335 |
2020 |
* |
Pathogenicity |
Optimization of activity localization of quinoline derivatives: Design, synthesis, and dual evaluation of biological activity for potential antitumor and antibacterial agents. |
Jin G, Li Z, Xiao F, Qi X, Sun X |
Bioorg Chem |
10.1016/j.bioorg.2020.103837 |
2020 |
* |
Enzymology |
Antifungal polyketide derivatives from the endophytic fungus Aplosporella javeedii. |
Gao Y, Wang L, Kalscheuer R, Liu Z, Proksch P |
Bioorg Med Chem |
10.1016/j.bmc.2020.115456 |
2020 |
* |
Enzymology |
Antimicrobial activity of endophytic fungi from the medicinal plants Mammea americana (Calophyllaceae) and Moringa oleifera (Moringaceae) |
Mosquera WG, Criado LY, Guerra BE |
Biomedica |
10.7705/biomedica.4644 |
2020 |
* |
Pathogenicity |
Identification of ica-dependent biofilm production by Staphylococcus aureus clinical isolates and antibiofilm effects of ascorbic acid against biofilm production. |
Kirmusaoglu S, Kasikci H |
J Clin Pathol |
10.1136/jclinpath-2019-206280 |
2020 |
* |
Pathogenicity |
Chemical composition and antibacterial activity of essential oils against pathogens often related to cattle endometritis. |
Braga Paiano R, Bonilla J, Moro de Sousa RL, Micke Moreno A, Sampaio Baruselli P |
J Infect Dev Ctries |
10.3855/jidc.12076 |
2020 |
* |
Pathogenicity |
Cladosins L-O, new hybrid polyketides from the endophytic fungus Cladosporium sphaerospermum WBS017. |
Pan F, El-Kashef DH, Kalscheuer R, Muller WEG, Lee J, Feldbrugge M, Mandi A, Kurtan T, Liu Z, Wu W, Proksch P |
Eur J Med Chem |
10.1016/j.ejmech.2020.112159 |
2020 |
* |
Metabolism |
Synthesis of naphthalimide derivatives with potential anticancer activity, their comparative ds- and G-quadruplex-DNA binding studies and related biological activities. |
Yildiz U, Kandemir I, Comert F, Akkoc S, Coban B |
Mol Biol Rep |
10.1007/s11033-019-05239-y |
2020 |
* |
Pathogenicity |
Design, Synthesis, and Dual Evaluation of Quinoline and Quinolinium Iodide Salt Derivatives as Potential Anticancer and Antibacterial Agents. |
Jin G, Xiao F, Li Z, Qi X, Zhao L, Sun X |
ChemMedChem |
10.1002/cmdc.202000002 |
2020 |
* |
Pathogenicity |
Inhibition of Drug Resistance of Staphylococcus aureus by Efflux Pump Inhibitor and Autolysis Inducer to Strengthen the Antibacterial Activity of beta-lactam Drugs. |
Luan W, Liu X, Wang X, An Y, Wang Y, Wang C, Shen K, Xu H, Li S, Liu M, Yu LU |
Pol J Microbiol |
10.33073/pjm-2019-047 |
2019 |
* |
Metabolism |
Green synthesis of ZnO nanoparticles with Veronica multifida and their antibiofilm activity. |
Dogan SS, Kocabas A |
Hum Exp Toxicol |
10.1177/0960327119888270 |
2019 |
* |
Pathogenicity |
In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa. |
Chan WY, Hickey EE, Khazandi M, Page SW, Trott DJ, Hill PB |
Vet Dermatol |
10.1111/vde.12803 |
2019 |
* |
Pathogenicity |
Vancomycin-loaded oxidized hyaluronic acid and adipic acid dihydrazide hydrogel: Bio-compatibility, drug release, antimicrobial activity, and biofilm model. |
Liao CH, Chen CS, Chen YC, Jiang NE, Farn CJ, Shen YS, Hsu ML, Chang CH |
J Microbiol Immunol Infect |
10.1016/j.jmii.2019.08.008 |
2019 |
* |
Pathogenicity |
Recent Patents on Impact of Lipopeptide on the Biofilm Formation onto Titanium and Stainless Steel Surfaces. |
Pires MEE, Parreira AG, Silva TNL, Colares HC, da Silva JA, de Magalhaes JT, Galdino AS, Goncalves DB, Granjeiro JM, Granjeiro PA |
Recent Pat Biotechnol |
10.2174/1872208313666190822150323 |
2020 |
* |
Metabolism |
Impact of co-cultivation with Enterococcus faecalis over growth, enterotoxin production and gene expression of Staphylococcus aureus in broth and fresh cheeses. |
Nogueira Vicosa G, Vieira Botelho C, Botta C, Bertolino M, Fernandes de Carvalho A, Nero LA, Cocolin L |
Int J Food Microbiol |
10.1016/j.ijfoodmicro.2019.108291 |
2019 |
* |
Pathogenicity |
Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker. |
Jin Z, Wang L, Gao H, Zhou YH, Liu YH, Tang YZ |
Eur J Med Chem |
10.1016/j.ejmech.2019.111594 |
2019 |
* |
Pathogenicity |
Bacterial inhibition efficiency of prilocaine and bupivacaine. |
Kesici S, Demirci M, Kesici U |
Int Wound J |
10.1111/iwj.13180 |
2019 |
* |
Pathogenicity |
Antibacterial effects of lidocaine and adrenaline. |
Kesici S, Demirci M, Kesici U |
Int Wound J |
10.1111/iwj.13182 |
2019 |
* |
Pathogenicity |
Prenylated flavonoid-enriched fraction from Maclura tinctoria shows biological activity against Staphylococcus aureus and protects Galleria mellonella larvae from bacterial infection. |
das Chagas Almeida A, Azevedo Rodrigues L, Dos Santos Paulino G, Pereira Aguilar A, Andrade Almeida A, Olavo Ferreira S, Brandao GC, Viana Leite JP, de Oliveira Barros Ribon A |
BMC Complement Altern Med |
10.1186/s12906-019-2600-y |
2019 |
* |
Pathogenicity |
In vitro evaluation of methicillin-resistant and methicillin-sensitive Staphylococcus aureus susceptibility to Saudi honeys. |
Hussain MB, Kamel YM, Ullah Z, Jiman-Fatani AAM, Ahmad AS |
BMC Complement Altern Med |
10.1186/s12906-019-2603-8 |
2019 |
* |
Cultivation |
Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin. |
Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP |
J Clin Microbiol |
10.1128/JCM.00567-19 |
2019 |
* |
Pathogenicity |
Investigation of silver nanoparticles on titanium surface created by ion implantation technology. |
Lampe I, Beke D, Biri S, Csarnovics I, Csik A, Dombradi Z, Hajdu P, Hegedus V, Racz R, Varga I, Hegedus C |
Int J Nanomedicine |
10.2147/IJN.S197782 |
2019 |
* |
Pathogenicity |
The Antibiofilm Effect of a Medical Device Containing TIAB on Microorganisms Associated with Surgical Site Infection. |
Puca V, Traini T, Guarnieri S, Carradori S, Sisto F, Macchione N, Muraro R, Mincione G, Grande R |
Molecules |
10.3390/molecules24122280 |
2019 |
* |
Pathogenicity |
Evaluation of Platensimycin and Platensimycin-Inspired Thioether Analogues against Methicillin-Resistant Staphylococcus aureus in Topical and Systemic Infection Mouse Models. |
Su M, Qiu L, Deng Y, Ruiz CH, Rudolf JD, Dong LB, Feng X, Cameron MD, Shen B, Duan Y, Huang Y |
Mol Pharm |
10.1021/acs.molpharmaceut.9b00293 |
2019 |
* |
Enzymology |
Pharmacokinetics and pharmacodynamics of intramammary cefquinome in lactating goats with and without experimentally induced Staphylococcus aureus mastitis. |
El Badawy SA, Amer AMM, Kamel GM, Eldeib KM, Constable PD |
J Vet Pharmacol Ther |
10.1111/jvp.12790 |
2019 |
* |
Metabolism |
Pharmacokinetic profile of amoxicillin and its glucuronide-like metabolite when administered subcutaneously to koalas (Phascolarctos cinereus). |
Kimble B, Vogelnest L, Gharibi S, Izes AM, Govendir M |
J Vet Pharmacol Ther |
10.1111/jvp.12767 |
2019 |
* |
Phylogeny |
Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions. |
Diaz-Roa A, Espinoza-Culupu A, Torres-Garcia O, Borges MM, Avino IN, Alves FL, Miranda A, Patarroyo MA, da Silva PI Jr, Bello FJ |
Molecules |
10.3390/molecules24112077 |
2019 |
* |
Pathogenicity |
Antimicrobial effects of local anaesthetics. |
Kesici U, Demirci M, Kesici S |
Int Wound J |
10.1111/iwj.13153 |
2019 |
* |
Pathogenicity |
Fabrication and physicochemical and antibacterial properties of ethyl cellulose-structured cinnamon oil oleogel: relation between ethyl cellulose viscosity and oleogel performance. |
Zhang K, Wang W, Wang X, Cheng S, Zhou J, Wu Z, Li Y |
J Sci Food Agric |
10.1002/jsfa.9636 |
2019 |
* |
Pathogenicity |
Antibiofilm Nitric Oxide-Releasing Polydopamine Coatings. |
Sadrearhami Z, Shafiee FN, Ho KKK, Kumar N, Krasowska M, Blencowe A, Wong EHH, Boyer C |
ACS Appl Mater Interfaces |
10.1021/acsami.8b16853 |
2019 |
* |
Pathogenicity |
Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics. |
Nussbaumer-Proll AK, Knotzer S, Eberl S, Reiter B, Stimpfl T, Jager W, Poschner S, Zeitlinger M |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-018-03452-4 |
2019 |
* |
Pathogenicity |
Antibacterial activity of Morinda citrifolia Linneo seeds against Methicillin-Resistant Staphylococcus spp. |
De La Cruz-Sanchez NG, Gomez-Rivera A, Alvarez-Fitz P, Ventura-Zapata E, Perez-Garcia MD, Aviles-Flores M, Gutierrez-Roman AS, Gonzalez-Cortazar M |
Microb Pathog |
10.1016/j.micpath.2019.01.030 |
2019 |
* |
Pathogenicity |
Antimicrobial effect of novel hydrogel matrix based on natural polysaccharide Sterculia urens. |
Lipovy B, Holoubek J, Vacek L, Ruzicka F, Nedomova E, Postulkova H, Vojtova L |
Epidemiol Mikrobiol Imunol |
107027 |
|
* |
Enzymology |
Staphylococcus aureus biofilm organization modulated by YycFG two-component regulatory pathway. |
Wu S, Huang F, Zhang H, Lei L |
J Orthop Surg Res |
10.1186/s13018-018-1055-z |
2019 |
* |
Metabolism |
Novel linear lipopeptide paenipeptin C' binds to lipopolysaccharides and lipoteichoic acid and exerts bactericidal activity by the disruption of cytoplasmic membrane. |
Moon SH, Huang E |
BMC Microbiol |
10.1186/s12866-018-1381-7 |
2019 |
* |
Enzymology |
Two new aromatic polyketides from a deep-sea fungus Penicillium sp. SCSIO 06720. |
Guo C, Lin XP, Liao SR, Yang B, Zhou XF, Yang XW, Tian XP, Wang JF, Liu YH |
Nat Prod Res |
10.1080/14786419.2018.1553880 |
2019 |
* |
Pathogenicity |
Chemical composition and antimicrobial activity of essential oil of Helichrysum italicum (Roth) G. Don fil. (Asteraceae) from Montenegro. |
Oliva A, Garzoli S, Sabatino M, Tadic V, Costantini S, Ragno R, Bozovic M |
Nat Prod Res |
10.1080/14786419.2018.1538218 |
2019 |
* |
Pathogenicity |
Transcriptome analysis of silver nanoparticles treated Staphylococcus aureus reveals potential targets for biofilm inhibition. |
Singh N, Rajwade J, Paknikar KM |
Colloids Surf B Biointerfaces |
10.1016/j.colsurfb.2018.12.032 |
2018 |
* |
Phylogeny |
Mollicellins O(-)R, Four New Depsidones Isolated from the Endophytic Fungus Chaetomium sp. Eef-10. |
Ouyang J, Mao Z, Guo H, Xie Y, Cui Z, Sun J, Wu H, Wen X, Wang J, Shan T |
Molecules |
10.3390/molecules23123218 |
2018 |
* |
Pathogenicity |
Identification of Anti-staphylococcal and Anti-biofilm Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box. |
Bhandari V, Chakraborty S, Brahma U, Sharma P |
Front Cell Infect Microbiol |
10.3389/fcimb.2018.00365 |
2018 |
* |
Enzymology |
Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate. |
Xiao J, Gill C, Liang L, Liu J, Wu J, Feng HP, Flanagan S, Tan C, Flattery A |
Antimicrob Agents Chemother |
10.1128/AAC.00822-18 |
2018 |
* |
Pathogenicity |
Impact of different pathophysiological conditions on antimicrobial activity of glycopeptides in vitro. |
Oesterreicher Z, Eberl S, Nussbaumer-Proell A, Peilensteiner T, Zeitlinger M |
Clin Microbiol Infect |
10.1016/j.cmi.2018.09.004 |
2018 |
* |
Pathogenicity |
Potential bactericidal activity of S. nux-vomica-ZnO nanocomposite against multidrug-resistant bacterial pathogens and wound-healing properties. |
Steffy K, Shanthi G, Maroky AS, Selvakumar S |
J Trace Elem Med Biol |
10.1016/j.jtemb.2018.07.009 |
2018 |
* |
Metabolism |
Antimicrobial and antioxidant activities of phenolic metabolites from flavonoid-producing yeast: Potential as natural food preservatives. |
Ng KR, Lyu X, Mark R, Chen WN |
Food Chem |
10.1016/j.foodchem.2018.07.077 |
2018 |
* |
Pathogenicity |
Biosynthesis of Ag, Se, and ZnO nanoparticles with antimicrobial activities against resistant pathogens using waste isolate Streptomyces enissocaesilis. |
Shaaban M, El-Mahdy AM |
IET Nanobiotechnol |
10.1049/iet-nbt.2017.0213 |
2018 |
* |
Biotechnology |
Simplistic approach in extracellular synthesis of silver nanoparticles via bioreducing potential of Planococcus plakortidis strain BGCC-51 isolated from dye industry effluent soil. |
Chokriwal A, Stephen BJ, Jain D, Singh A |
IET Nanobiotechnol |
10.1049/iet-nbt.2017.0251 |
2018 |
* |
Pathogenicity |
Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides. |
Pospisilova S, Kos J, Michnova H, Kapustikova I, Strharsky T, Oravec M, Moricz AM, Bakonyi J, Kauerova T, Kollar P, Cizek A, Jampilek J |
Int J Mol Sci |
10.3390/ijms19082318 |
2018 |
* |
Pathogenicity |
Synthesis and characterization of ZnO phytonanocomposite using Strychnos nux-vomica L. (Loganiaceae) and antimicrobial activity against multidrug-resistant bacterial strains from diabetic foot ulcer. |
Steffy K, Shanthi G, Maroky AS, Selvakumar S |
J Adv Res |
10.1016/j.jare.2017.11.001 |
2017 |
* |
Pathogenicity |
Phenotype and RNA-seq-Based transcriptome profiling of Staphylococcus aureus biofilms in response to tea tree oil. |
Zhao X, Liu Z, Liu Z, Meng R, Shi C, Chen X, Bu X, Guo N |
Microb Pathog |
10.1016/j.micpath.2018.07.027 |
2018 |
* |
Metabolism |
Covalent Whey Protein-Rosmarinic Acid Interactions: A Comparison of Alkaline and Enzymatic Modifications on Physicochemical, Antioxidative, and Antibacterial Properties. |
Ali M, Keppler JK, Coenye T, Schwarz K |
J Food Sci |
10.1111/1750-3841.14222 |
2018 |
* |
Pathogenicity |
The antimicrobial spectrum of lysozyme broadened by reductive modification. |
Liu J, Wang N, Liu Y, Jin Y, Ma M |
Poult Sci |
10.3382/ps/pey245 |
2018 |
* |
Pathogenicity |
Inhibitory Effect of 2R,3R-Dihydromyricetin on Biofilm Formation by Staphylococcus aureus. |
Wu YP, Bai JR, Grosu E, Zhong K, Liu LJ, Tang MM, Huang YN, Gao H |
Foodborne Pathog Dis |
10.1089/fpd.2017.2405 |
2018 |
* |
Metabolism |
Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety. |
Zhang ZS, Huang YZ, Luo J, Jin Z, Liu YH, Tang YZ |
Chem Biol Drug Des |
10.1111/cbdd.13328 |
2018 |
* |
Pathogenicity |
The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study. |
Alonso B, Perez-Granda MJ, Rodriguez-Huerta A, Rodriguez C, Bouza E, Guembe M |
J Hosp Infect |
10.1016/j.jhin.2018.04.007 |
2018 |
* |
Metabolism |
Staphylococcus aureus undergoes major transcriptional reorganization during growth with Enterococcus faecalis in milk. |
Vicosa GN, Botta C, Ferrocino I, Bertolino M, Ventura M, Nero LA, Cocolin L |
Food Microbiol |
10.1016/j.fm.2018.01.007 |
2018 |
* |
Pathogenicity |
From bugs to drugs: Combating antimicrobial resistance by discovering novel antibiotics. |
Abou Fayad A, Itani D, Miari M, Tanelian A, Iweir S, Matar GM |
J Infect Dev Ctries |
10.3855/jidc.10108 |
2018 |
* |
Pathogenicity |
In vitro evaluation of new 2-phenoxy-benzo[g][1,2,4]triazolo[1,5-a]quinazoline derivatives as antimicrobial agents. |
Abuelizz HA, El-Dib RA, Marzouk M, Al-Salahi R |
Microb Pathog |
10.1016/j.micpath.2018.02.018 |
2018 |
* |
Enzymology |
Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim. |
Park JH, Craig W, Marchillo K, Huang DB, Andes DR |
Antimicrob Agents Chemother |
10.1128/AAC.02550-17 |
2018 |
* |
Pathogenicity |
Anti-endotoxin mechanism of the KW4 peptide in inflammation in RAW 264.7 cells induced by LTA and drug-resistant Staphylococcus aureus 1630. |
Lee JK, Park Y |
Amino Acids |
10.1007/s00726-017-2518-y |
2017 |
* |
Pathogenicity |
Survivability and fitness cost of heterogeneous vancomycin-intermediate Staphylococcus aureus. |
Singh A, Singh S, Singh J, Rahman M, Pathak A, Prasad KN |
Indian J Med Microbiol |
10.4103/ijmm.IJMM_17_311 |
2017 |
* |
Stress |
Production and mechanical properties of Ti-5Al-2.5Fe-xCu alloys for biomedical applications. |
Yamanoglu R, Efendi E, Kolayli F, Uzuner H, Daoud I |
Biomed Mater |
10.1088/1748-605X/aa957d |
2018 |
* |
Pathogenicity |
In Vitro Evaluation of Povidone-Iodine and Chlorhexidine against Outbreak and Nonoutbreak Strains of Mycobacterium abscessus Using Standard Quantitative Suspension and Carrier Testing. |
Cheng A, Sun HY, Tsai YT, Wu UI, Chuang YC, Wang JT, Sheng WH, Hsueh PR, Chen YC, Chang SC |
Antimicrob Agents Chemother |
10.1128/AAC.01364-17 |
2017 |
* |
Pathogenicity |
Comparative analysis of methicillin-sensitive and resistant Staphylococcus aureus exposed to emodin based on proteomic profiling. |
Ji X, Liu X, Peng Y, Zhan R, Xu H, Ge X |
Biochem Biophys Res Commun |
10.1016/j.bbrc.2017.10.033 |
2017 |
* |
Pathogenicity |
[Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures]. |
Kesli R, Bilgin H, Yilmaz H |
Mikrobiyol Bul |
10.5578/mb.57362 |
2017 |
* |
Pathogenicity |
Lactococcus lactis as a safe and inexpensive source of bioactive silver composites. |
Viorica RP, Pawel P, Kinga M, Michal Z, Katarzyna R, Boguslaw B |
Appl Microbiol Biotechnol |
10.1007/s00253-017-8443-x |
2017 |
* |
Enzymology |
Drawbacks of the use of cotrimoxazole in foreign-body infections. |
El Haj C, Ribera A, Lloberas N, Tubau F, Ariza J, Murillo O |
Enferm Infecc Microbiol Clin (Engl Ed) |
10.1016/j.eimc.2017.07.005 |
2017 |
* |
Phylogeny |
Saccharopolyspora hattusasensis sp. nov., isolated from soil. |
Veyisoglu A, Saygin H, Tatar D, Bektas KI, Sahin N |
Antonie Van Leeuwenhoek |
10.1007/s10482-017-0921-8 |
2017 |
* |
Pathogenicity |
Aloe-emodin inhibits Staphylococcus aureus biofilms and extracellular protein production at the initial adhesion stage of biofilm development. |
Xiang H, Cao F, Ming D, Zheng Y, Dong X, Zhong X, Mu D, Li B, Zhong L, Cao J, Wang L, Ma H, Wang T, Wang D |
Appl Microbiol Biotechnol |
10.1007/s00253-017-8403-5 |
2017 |
* |
Pathogenicity |
Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study. |
Greimel F, Scheuerer C, Gessner A, Simon M, Kalteis T, Grifka J, Benditz A, Springorum HR, Schaumburger J |
Drug Des Devel Ther |
10.2147/DDDT.S138888 |
2017 |
* |
Phylogeny |
Antimicrobial investigation of selected soil actinomycetes isolated from unexplored regions of Kashmir Himalayas, India. |
Shah AM, Shakeel-U-Rehman, Hussain A, Mushtaq S, Rather MA, Shah A, Ahmad Z, Khan IA, Bhat KA, Hassan QP |
Microb Pathog |
10.1016/j.micpath.2017.06.017 |
2017 |
* |
Pathogenicity |
Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs. |
El-Gohary NS, Shaaban MI |
Eur J Med Chem |
10.1016/j.ejmech.2017.05.064 |
2017 |
* |
Pathogenicity |
Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms. |
Giovagnoli S, Pietrella D, Barberini L, Santi C, Carotti A, di Michele A, Ricci M |
Int J Pharm |
10.1016/j.ijpharm.2017.06.008 |
2017 |
* |
Pathogenicity |
Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures. |
Miller N, Brassinne L, Allemeersch D |
Acta Clin Belg |
10.1080/17843286.2017.1331618 |
2017 |
* |
Pathogenicity |
THERAPEUTIC POTENTIALS OF ETHANOLIC EXTRACT OF LEAVES OF HOLARRHENA FLORIBUNDA (G. DON) DUR. AND SCHINZ (APOCYNACEAE). |
Hoekou YP, Tchacondo T, Karou SD, Yerbanga RS, Achoribo E, Da O, Atakpama W, Batawila K |
Afr J Tradit Complement Altern Med |
10.21010/ajtcam.v14i2.24 |
2017 |
* |
Pathogenicity |
Two new kaurane-type diterpenoids from Wedelia chinensis (Osbeck.) Merr. |
Cai C, Zhang Y, Yang D, Hao X, Li S |
Nat Prod Res |
10.1080/14786419.2017.1317775 |
2017 |
* |
Pathogenicity |
Synthesis and Bioactivity Evaluation of Novel 2-Salicyloylbenzofurans as Antibacterial Agents. |
Phan PT, Nguyen TT, Nguyen HT, Le BN, Vu TT, Tran DC, Pham TN |
Molecules |
10.3390/molecules22050687 |
2017 |
* |
Pathogenicity |
Antibacterial Activity of Desert Truffles from Saudi Arabia Against Staphylococcus aureus and Pseudomonas aeruginosa. |
Schillaci D, Cusimano MG, Cascioferro SM, Di Stefano V, Arizza V, Chiaramonte M, Inguglia L, Bawadekji A, Davino S, Gargano ML, Venturella G |
Int J Med Mushrooms |
10.1615/IntJMedMushrooms.v19.i2.30 |
2017 |
* |
Pathogenicity |
Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA). |
Aruldass CA, Masalamany SRL, Venil CK, Ahmad WA |
Environ Sci Pollut Res Int |
10.1007/s11356-017-8855-2 |
2017 |
* |
Pathogenicity |
In situ development and application of natural coatings on non-absorbable sutures to reduce incision site infections. |
Masood R, Hussain T, Umar M, Azeemullah, Areeb T, Riaz S |
J Wound Care |
10.12968/jowc.2017.26.3.115 |
2017 |
* |
Pathogenicity |
Poly(carboxylic acid)-Cyclodextrin/Anionic Porphyrin Finished Fabrics as Photosensitizer Releasers for Antimicrobial Photodynamic Therapy. |
Castriciano MA, Zagami R, Casaletto MP, Martel B, Trapani M, Romeo A, Villari V, Sciortino MT, Grasso L, Guglielmino S, Scolaro LM, Mazzaglia A |
Biomacromolecules |
10.1021/acs.biomac.6b01752 |
2017 |
* |
Phylogeny |
Microbiological analysis, antimicrobial activity, and heavy-metals content of Jordanian Ma'in hot-springs water. |
Shakhatreh MAK, Jacob JH, Hussein EI, Masadeh MM, Obeidat SM, Juhmani AF, Abd Al-Razaq MA |
J Infect Public Health |
10.1016/j.jiph.2017.01.010 |
2017 |
* |
Metabolism |
Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker. |
Gao ML, Zeng J, Fang X, Luo J, Jin Z, Liu YH, Tang YZ |
Eur J Med Chem |
10.1016/j.ejmech.2017.01.004 |
2017 |
* |
Phylogeny |
Burkholderia paludis sp. nov., an Antibiotic-Siderophore Producing Novel Burkholderia cepacia Complex Species, Isolated from Malaysian Tropical Peat Swamp Soil. |
Ong KS, Aw YK, Lee LH, Yule CM, Cheow YL, Lee SM |
Front Microbiol |
10.3389/fmicb.2016.02046 |
2016 |
* |
Pathogenicity |
iTRAQ-based proteome analysis of fluoroquinolone-resistant Staphylococcus aureus. |
Thai VC, Lim TK, Le KPU, Lin Q, Nguyen TTH |
J Glob Antimicrob Resist |
10.1016/j.jgar.2016.11.003 |
2016 |
* |
Proteome |
Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself. |
Ambrose PG, VanScoy B, Conde H, McCauley J, Rubino CM, Bhavnani SM |
Antimicrob Agents Chemother |
10.1128/AAC.01605-16 |
2016 |
* |
Transcriptome |
Comparative virulence studies and transcriptome analysis of Staphylococcus aureus strains isolated from animals. |
Iqbal Z, Seleem MN, Hussain HI, Huang L, Hao H, Yuan Z |
Sci Rep |
10.1038/srep35442 |
2016 |
* |
Pathogenicity |
Antimicrobial evaluation of selected naturally occurring oxyprenylated secondary metabolites. |
Di Giulio M, Genovese S, Fiorito S, Epifano F, Nostro A, Cellini L |
Nat Prod Res |
10.1080/14786419.2015.1079908 |
2015 |
* |
Enzymology |
[Bioactive quinolizidine alkaloids from Sophora tonkinensis]. |
Zhang Y, Hu WZ, Chen XZ, Peng YB, Song LY, Shi YS |
Zhongguo Zhong Yao Za Zhi |
10.4268/cjcmm20161215 |
2016 |
* |
Enzymology |
In vivo bactericidal efficacy of farnesol on Ti6Al4V implants. |
Constantino JA, Delgado-Rastrollo M, Pacha-Olivenza MA, Perez-Giraldo C, Quiles M, Gonzalez-Martin ML, Gallardo-Moreno AM |
Rev Esp Cir Ortop Traumatol |
10.1016/j.recot.2016.04.004 |
2016 |
* |
Pathogenicity |
[ABILITY OF STAPHYLOCOCCUS OF VARIOUS STRAINS TO CREATE BIOFILMS AND THEIR EFFECT ON HUMAN BODY CELLS]. |
Kornienko MA, Kopyltsov VN, Shevlyagina NV, Didenko LV, Lyubasovskaya LA, Priputnevich TV, Ilina EN |
Mol Gen Mikrobiol Virusol |
|
2016 |
* |
Metabolism |
Studies on bioactivity and secondary metabolites of crude extracts of Bidens pilosa L. (Asteraceae): A medicinal plant used in the Transkei region of South Africa. |
Njume C, Gqaza BM, Rozani C, Goduka NI |
Pak J Pharm Sci |
|
2016 |
* |
Pathogenicity |
Enhanced nanocurcumin toxicity against (PC3) tumor and microbial by using magnetic field in vitro. |
Aldahoun MA, Jaafar MS, Al-Akhras MH, Bououdina M |
Artif Cells Nanomed Biotechnol |
10.1080/21691401.2016.1178137 |
2016 |
* |
Pathogenicity |
Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis. |
Saidykhan L, Abu Bakar MZ, Rukayadi Y, Kura AU, Latifah SY |
Int J Nanomedicine |
10.2147/IJN.S95885 |
2016 |
* |
Pathogenicity |
Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1,8-cineole against Staphylococcus aureus planktonic and biofilm growth. |
Kifer D, Muzinic V, Klaric MS |
J Antibiot (Tokyo) |
10.1038/ja.2016.10 |
2016 |
* |
Metabolism |
Evaluation of Antibacterial Activity and Reactive Species Generation of N-Benzenesulfonyl Derivatives of Heterocycles. |
Martinez SR, Miana GE, Albesa I, Mazzieri MR, Becerra MC |
Chem Pharm Bull (Tokyo) |
10.1248/cpb.c15-00682 |
2016 |
* |
Pathogenicity |
Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo. |
Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H |
Molecules |
10.3390/molecules21010062 |
2016 |
* |
Pathogenicity |
Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. |
Adahoun MA, Al-Akhras MH, Jaafar MS, Bououdina M |
Artif Cells Nanomed Biotechnol |
10.3109/21691401.2015.1129628 |
2016 |
* |
Pathogenicity |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
Meng Y, Hou X, Lei J, Chen M, Cong S, Zhang Y, Ding W, Li G, Li X |
Pharm Res |
10.1007/s11095-015-1825-9 |
2015 |
* |
Pathogenicity |
Synthesis of biscoumarin and dihydropyran derivatives with promising antitumor and antibacterial activities. |
Li J, Sui YP, Xin JJ, Du XL, Li JT, Huo HR, Ma H, Wang WH, Zhou HY, Zhan HD, Wang ZJ, Li C, Sui F, Li X |
Bioorg Med Chem Lett |
10.1016/j.bmcl.2015.10.063 |
2015 |
* |
Pathogenicity |
Standardization of Operator-Dependent Variables Affecting Precision and Accuracy of the Disk Diffusion Method for Antibiotic Susceptibility Testing. |
Hombach M, Maurer FP, Pfiffner T, Bottger EC, Furrer R |
J Clin Microbiol |
10.1128/JCM.02351-15 |
2015 |
* |
Genetics |
Draft Genome Sequence of Methicillin-Sensitive Staphylococcus aureus ATCC 29213. |
Soni I, Chakrapani H, Chopra S |
Genome Announc |
10.1128/genomeA.01095-15 |
2015 |
* |
Pathogenicity |
Synthesis of Biscoumarin and Dihydropyran Derivatives and Evaluation of Their Antibacterial Activity. |
Li J, Lv CW, Li XJ, Qu D, Hou Z, Jia M, Luo XX, Li X, Li MK |
Molecules |
10.3390/molecules200917469 |
2015 |
* |
Pathogenicity |
Anti-biofilm activity of ultrashort cinnamic acid peptide derivatives against medical device-related pathogens. |
Laverty G, McCloskey AP, Gorman SP, Gilmore BF |
J Pept Sci |
10.1002/psc.2805 |
2015 |
* |
Pathogenicity |
Potency and penetration of telavancin in staphylococcal biofilms. |
Kirker KR, Fisher ST, James GA |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2015.05.022 |
2015 |
* |
Pathogenicity |
Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies. |
Alanazi AM, Abdel-Aziz AA, Shawer TZ, Ayyad RR, Al-Obaid AM, Al-Agamy MH, Maarouf AR, El-Azab AS |
J Enzyme Inhib Med Chem |
10.3109/14756366.2015.1060482 |
2015 |
* |
Pathogenicity |
Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA). |
Zadrazilova I, Pospisilova S, Masarikova M, Imramovsky A, Ferriz JM, Vinsova J, Cizek A, Jampilek J |
Eur J Pharm Sci |
10.1016/j.ejps.2015.06.009 |
2015 |
* |
Pathogenicity |
Synthesis of biscoumarin and dihydropyran derivatives as two novel classes of potential anti-bacterial derivatives. |
Li J, Xue XY, Li X, Hou Z, Yang XH, Qu D, Zhou Y, Zhang ZD, Luo XX, Li JT, Li MK |
Arch Pharm Res |
10.1007/s12272-015-0614-7 |
2015 |
* |
Pathogenicity |
Synergy between baicalein and penicillins against penicillinase-producing Staphylococcus aureus. |
Qian M, Tang S, Wu C, Wang Y, He T, Chen T, Xiao X |
Int J Med Microbiol |
10.1016/j.ijmm.2015.05.001 |
2015 |
* |
Cultivation |
Microbial fuel cell-based diagnostic platform to reveal antibacterial effect of beta-lactam antibiotics. |
Schneider G, Czeller M, Rostas V, Kovacs T |
Enzyme Microb Technol |
10.1016/j.enzmictec.2015.04.004 |
2015 |
* |
Phylogeny |
Development of a novel matrix-assisted laser desorption/ionization time-of-flight mass spectrum (MALDI-TOF-MS)-based typing method to identify meticillin-resistant Staphylococcus aureus clones. |
Ueda O, Tanaka S, Nagasawa Z, Hanaki H, Shobuike T, Miyamoto H |
J Hosp Infect |
10.1016/j.jhin.2014.11.025 |
2015 |
* |
Phylogeny |
Bacillus subtilis subsp. subtilis CBMDC3f with antimicrobial activity against Gram-positive foodborne pathogenic bacteria: UV-MALDI-TOF MS analysis of its bioactive compounds. |
Torres MJ, Petroselli G, Daz M, Erra-Balsells R, Audisio MC |
World J Microbiol Biotechnol |
10.1007/s11274-015-1847-9 |
2015 |
* |
Pathogenicity |
Preparation of gentamicin dioctyl sulfosuccinate loaded poly(trimethylene carbonate) matrices intended for the treatment of orthopaedic infections. |
ter Boo GA, Grijpma DW, Richards RG, Moriarty TF, Eglin D |
Clin Hemorheol Microcirc |
10.3233/CH-151935 |
2015 |
* |
Pathogenicity |
Antimicrobial activity of natural products from the flora of Northern Ontario, Canada. |
Vandal J, Abou-Zaid MM, Ferroni G, Leduc LG |
Pharm Biol |
10.3109/13880209.2014.942867 |
2015 |
* |
Pathogenicity |
Anti-virulence potential of eugenyl acetate against pathogenic bacteria of medical importance. |
Musthafa KS, Voravuthikunchai SP |
Antonie Van Leeuwenhoek |
10.1007/s10482-014-0364-4 |
2015 |
* |
Pathogenicity |
Synthesis and pharmacological evaluations of 4-hydroxycoumarin derivatives as a new class of anti-Staphylococcus aureus agents. |
Li ZP, Li J, Qu D, Hou Z, Yang XH, Zhang ZD, Wang YK, Luo XX, Li MK |
J Pharm Pharmacol |
10.1111/jphp.12343 |
2014 |
* |
Pathogenicity |
[Influence of Chlorhexidine and Prontosan on Dual Species and Monospecies Biofilms Formed by Staphylococcus aureus and Pseudomonas aeruginosa]. |
Kuznetsova MV, Encheva YA, Samartsev VA |
Antibiot Khimioter |
|
2015 |
* |
Pathogenicity |
New biscoumarin derivatives: synthesis, crystal structure, theoretical study and antibacterial activity against Staphylococcus aureus. |
Qu D, Li J, Yang XH, Zhang ZD, Luo XX, Li MK, Li X |
Molecules |
10.3390/molecules191219868 |
2014 |
* |
Pathogenicity |
Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin. |
Mei Q, Ye Y, Zhu YL, Cheng J, Chang X, Liu YY, Li HR, Li JB |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-014-2285-6 |
2014 |
* |
Enzymology |
Antibacterial and anti-biofilm activity of flavonoids and triterpenes isolated from the extracts of Ficus sansibarica Warb. subsp. sansibarica (Moraceae) extracts. |
Awolola GV, Koorbanally NA, Chenia H, Shode FO, Baijnath H |
Afr J Tradit Complement Altern Med |
10.4314/ajtcam.v11i3.19 |
2014 |
* |
Enzymology |
Selection of potential probiotic Enterococcus faecium isolated from Portuguese fermented food. |
Barbosa J, Borges S, Teixeira P |
Int J Food Microbiol |
10.1016/j.ijfoodmicro.2014.09.009 |
2014 |
* |
Pathogenicity |
Synergistic interaction of PMAP-36 and PRW4 with aminoglycoside antibiotics and their antibacterial mechanism. |
Wang Z, Zhang L, Wang J, Wei D, Shi B, Shan A |
World J Microbiol Biotechnol |
10.1007/s11274-014-1739-4 |
2014 |
* |
Pathogenicity |
Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene. |
Locke JB, Zuill DE, Scharn CR, Deane J, Sahm DF, Denys GA, Goering RV, Shaw KJ |
Antimicrob Agents Chemother |
10.1128/AAC.03493-14 |
2014 |
* |
Pathogenicity |
Cobalt(II) complexes with the antimicrobial drug enrofloxacin: structure, antimicrobial activity, DNA- and albumin-binding. |
Protogeraki C, Andreadou EG, Perdih F, Turel I, Pantazaki AA, Psomas G |
Eur J Med Chem |
10.1016/j.ejmech.2014.08.043 |
2014 |
* |
Pathogenicity |
Cationic synthetic peptides: assessment of their antimicrobial potency in liquid preserved boar semen. |
Speck S, Courtiol A, Junkes C, Dathe M, Muller K, Schulze M |
PLoS One |
10.1371/journal.pone.0105949 |
2014 |
* |
Enzymology |
Pathogen removal during wastewater treatment by vermifiltration. |
Arora S, Rajpal A, Kumar T, Bhargava R, Kazmi AA |
Environ Technol |
10.1080/09593330.2014.911358 |
2014 |
* |
Pathogenicity |
Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical center. |
Locke JB, Zuill DE, Scharn CR, Deane J, Sahm DF, Goering RV, Jenkins SG, Shaw KJ |
Antimicrob Agents Chemother |
10.1128/AAC.03380-14 |
2014 |
* |
Pathogenicity |
Recombinant scorpine produced using SUMO fusion partner in Escherichia coli has the activities against clinically isolated bacteria and inhibits the Plasmodium falciparum parasitemia in vitro. |
Zhang C, He X, Gu Y, Zhou H, Cao J, Gao Q |
PLoS One |
10.1371/journal.pone.0103456 |
2014 |
* |
Pathogenicity |
Influence of physico-chemical material characteristics on staphylococcal biofilm formation--a qualitative and quantitative in vitro analysis of five different calcium phosphate bone grafts. |
Clauss M, Furustrand Tafin U, Betrisey B, van Garderen N, Trampuz A, Ilchmann T, Bohner M |
Eur Cell Mater |
10.22203/ecm.v028a04 |
2014 |
* |
Pathogenicity |
Antimicrobial, insecticidal and phytotoxic activities of Cotinus coggyria Scop. essential oil (Anacardiaceae). |
Ulukanli Z, Karaborklu S, Bozok F, Cenet M, Ozturk B, Balcilar M |
Nat Prod Res |
10.1080/14786419.2014.928879 |
2014 |
* |
Pathogenicity |
Synthesis, antibacterial activities, and theoretical studies of dicoumarols. |
Li J, Hou Z, Chen GH, Li F, Zhou Y, Xue XY, Li ZP, Jia M, Zhang ZD, Li MK, Luo XX |
Org Biomol Chem |
10.1039/c4ob00772g |
2014 |
* |
Pathogenicity |
Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method. |
Ross JE, Mendes RE, Jones RN |
J Clin Microbiol |
10.1128/JCM.01210-14 |
2014 |
* |
Pathogenicity |
Effect of subinhibitory concentrations of chlorogenic acid on reducing the virulence factor production by Staphylococcus aureus. |
Li G, Qiao M, Guo Y, Wang X, Xu Y, Xia X |
Foodborne Pathog Dis |
10.1089/fpd.2013.1731 |
2014 |
* |
Enzymology |
Sensitive and selective near-infrared fluorescent off-on probe and its application to imaging different levels of beta-lactamase in Staphylococcus aureus. |
Li L, Li Z, Shi W, Li X, Ma H |
Anal Chem |
10.1021/ac501288e |
2014 |
* |
Pathogenicity |
In vitro evaluation of antimicrobial features of sugammadex. |
Hanci V, Vural A, Hanci SY, Ali Kiraz H, Omur D, Unver A |
Braz J Anesthesiol |
10.1016/j.bjane.2013.09.003 |
2013 |
* |
Pathogenicity |
[A study of the single nucleotide polymorphism fragments of the AUR gene metalloprotease strains of Staphylococcus aureus isolated from the skin of patients with atopic dermatitis]. |
Tuyrin YA, Shamsutdinov AF, Fassahov RS |
Mol Gen Mikrobiol Virusol |
|
2014 |
* |
Pathogenicity |
Negative-pressure wound therapy enhances local inflammatory responses in acute infected soft-tissue wound. |
Liu D, Zhang L, Li T, Wang G, Du H, Hou H, Han L, Tang P |
Cell Biochem Biophys |
10.1007/s12013-014-9953-0 |
2014 |
* |
Pathogenicity |
Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-mug disk. |
Koeth LM, Matuschek E, Kahlmeter G, Alm RA, Ambler JE |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-014-2089-8 |
2014 |
* |
Enzymology |
Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I. |
Huang Y, Xu Y, Liu S, Wang H, Xu X, Guo Q, Wu B, Gordeev MF, Wang W, Yuan Z, Wang M |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2014.02.008 |
2014 |
* |
Pathogenicity |
Extracorporeal shockwave increases the effectiveness of systemic antibiotic treatment in implant-related chronic osteomyelitis: experimental study in a rat model. |
Inanmaz ME, Uslu M, Isik C, Kaya E, Tas T, Bayram R |
J Orthop Res |
10.1002/jor.22604 |
2014 |
* |
Enzymology |
Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection. |
Wang J, Shan Q, Ding H, Liang C, Zeng Z |
Antimicrob Agents Chemother |
10.1128/AAC.01666-13 |
2014 |
* |
Pathogenicity |
Synthesis of novel 2-(substituted amino)alkylthiopyrimidin-4(3H)-ones as potential antimicrobial agents. |
Attia MI, El-Emam AA, Al-Turkistani AA, Kansoh AL, El-Brollosy NR |
Molecules |
10.3390/molecules19010279 |
2013 |
* |
Pathogenicity |
Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)ace tyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents. |
Suresh N, Nagesh HN, Renuka J, Rajput V, Sharma R, Khan IA, Kondapalli Venkata Gowri CS |
Eur J Med Chem |
10.1016/j.ejmech.2013.10.055 |
2013 |
* |
Pathogenicity |
Cytotoxic and antibacterial marfuraquinocins from the deep South China Sea-derived Streptomyces niveus SCSIO 3406. |
Song Y, Huang H, Chen Y, Ding J, Zhang Y, Sun A, Zhang W, Ju J |
J Nat Prod |
10.1021/np4006025 |
2013 |
* |
Pathogenicity |
In vitro evaluation of the minimum bactericidal concentrations of different root-end filling materials. |
Kocak MM, Kocak S, Oktay EA, Kilic A, Yaman SD |
J Contemp Dent Pract |
10.5005/jp-journals-10024-1330 |
2013 |
* |
Pathogenicity |
Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study. |
Gunes H, Gulen D, Mutlu R, Gumus A, Tas T, Topkaya AE |
Toxicol Ind Health |
10.1177/0748233713498458 |
2013 |
* |
Pathogenicity |
Synthesis, crystal structures, and anti-drug-resistant Staphylococcus aureus activities of novel 4-hydroxycoumarin derivatives. |
Li MK, Li J, Liu BH, Zhou Y, Li X, Xue XY, Hou Z, Luo XX |
Eur J Pharmacol |
10.1016/j.ejphar.2013.09.040 |
2013 |
* |
Pathogenicity |
Probiotic properties of lactobacilli species isolated from children's feces. |
Tulumoglu S, Yuksekdag ZN, Beyatli Y, Simsek O, Cinar B, Yasar E |
Anaerobe |
10.1016/j.anaerobe.2013.09.006 |
2013 |
* |
Enzymology |
Detection and enumeration of Staphylococcus aureus from bovine milk samples by real-time polymerase chain reaction. |
Botaro BG, Cortinhas CS, Marco LV, Moreno JFG, Silva LFP, Benites NR, Santos MV |
J Dairy Sci |
10.3168/jds.2013-6559 |
2013 |
* |
Enzymology |
Bioactive polyketides and alkaloids from Penicillium citrinum, a fungal endophyte isolated from Ocimum tenuiflorum. |
Lai D, Brotz-Oesterhelt H, Muller WEG, Wray V, Proksch P |
Fitoterapia |
10.1016/j.fitote.2013.08.017 |
2013 |
* |
Pathogenicity |
[Effect of cinnamon and lavender oils on FtsZ gene expression in the Staphylococus aureus ATCC 29213]. |
Herman A, Bochenek J, Herman AP |
Prikl Biokhim Mikrobiol |
|
2013 |
* |
Pathogenicity |
Comparison of chlorine dioxide and dichloroisocyanurate disinfectants for use in the dental setting. |
Patel M, Ebonwu J, Cutler E |
SADJ |
|
2012 |
* |
Metabolism |
Differential adaptive responses of Staphylococcus aureus to in vitro selection with different antimicrobial peptides. |
Shireen T, Singh M, Das T, Mukhopadhyay K |
Antimicrob Agents Chemother |
10.1128/AAC.00780-13 |
2013 |
* |
Enzymology |
Antibacterial and cytotoxic new napyradiomycins from the marine-derived Streptomyces sp. SCSIO 10428. |
Wu Z, Li S, Li J, Chen Y, Saurav K, Zhang Q, Zhang H, Zhang W, Zhang W, Zhang S, Zhang C |
Mar Drugs |
10.3390/md11062113 |
2013 |
* |
Enzymology |
New antibacterial germacrene from Verbesina negrensis. |
Mora FD, Alpan L, de Tommasi N, McCracken VJ, Nieto M |
Planta Med |
10.1055/s-0032-1328542 |
2013 |
* |
Pathogenicity |
Antimicrobial activity of newly synthesized methylsulfanyl-triazoloquinazoline derivatives. |
Al-Salahi R, Marzouk M, Awad G, Al-Omar M, Ezzeldin E |
J Pharm Pharmacol |
10.1111/jphp.12039 |
2013 |
* |
Pathogenicity |
Effects of selenium coating of orthopaedic implant surfaces on bacterial adherence and osteoblastic cell growth. |
Holinka J, Pilz M, Kubista B, Presterl E, Windhager R |
Bone Joint J |
10.1302/0301-620X.95B5.31216 |
2013 |
* |
Pathogenicity |
Antimicrobial/anti-biofilm activity of expired blood platelets and their released products. |
Rozalski MI, Micota B, Sadowska B, Paszkiewicz M, Wieckowska-Szakiel M, Rozalska B |
Postepy Hig Med Dosw (Online) |
10.5604/17322693.1046009 |
2013 |
* |
Pathogenicity |
Effects of Zataria multiflora Boiss. essential oil on growth and gene expression of enterotoxins A, C and E in Staphylococcus aureus ATCC 29213. |
Azizkhani M, Misaghi A, Basti AA, Gandomi H, Hosseini H |
Int J Food Microbiol |
10.1016/j.ijfoodmicro.2013.02.020 |
2013 |
* |
Pathogenicity |
Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus. |
Diaz L, Kontoyiannis DP, Panesso D, Albert ND, Singh KV, Tran TT, Munita JM, Murray BE, Arias CA |
J Infect Dis |
10.1093/infdis/jit138 |
2013 |
* |
Enzymology |
Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model. |
Banevicius MA, Kaplan N, Hafkin B, Nicolau DP |
J Chemother |
10.1179/1973947812Y.0000000061 |
2013 |
* |
Pathogenicity |
Biofilm formation by staphylococci on fresh, fresh-frozen and processed human and bovine bone grafts. |
Clauss M, Tafin UF, Bizzini A, Trampuz A, Ilchmann T |
Eur Cell Mater |
10.22203/ecm.v025a11 |
2013 |
* |
Enzymology |
A rabbit model of right-sided Staphylococcus aureus endocarditis created with echocardiographic guidance. |
Wang ML, Zhang Y, Fan M, Guo YJ, Ren WD, Luo EJ |
Cardiovasc Ultrasound |
10.1186/1476-7120-11-3 |
2013 |
* |
Pathogenicity |
New type of protective hybrid and nanocomposite hybrid coatings containing silver and copper with an excellent antibacterial effect especially against MRSA. |
Slamborova I, Zajicova V, Karpiskova J, Exnar P, Stibor I |
Mater Sci Eng C Mater Biol Appl |
10.1016/j.msec.2012.08.039 |
2012 |
* |
Pathogenicity |
Comparison of Rosco Neo-Sensitabs with Oxoid paper disks in EUCAST disk diffusion antimicrobial susceptibility testing on Mueller-Hinton agar. |
Justesen US, Acar Z, Olsson K, Jensen TG, Kerrn MB, Skov RL, Gahrn-Hansen B |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-012-1785-5 |
2012 |
* |
Pathogenicity |
In vitro pharmacodynamics of AZD5206 against Staphylococcus aureus. |
Tam VH, Chang KT, Yang Z, Newman J, Hu M |
Antimicrob Agents Chemother |
10.1128/AAC.01208-12 |
2012 |
* |
Pathogenicity |
Fluostatins I-K from the South China Sea-derived micromonospora rosaria SCSIO N160. |
Zhang W, Liu Z, Li S, Lu Y, Chen Y, Zhang H, Zhang G, Zhu Y, Zhang G, Zhang W, Liu J, Zhang C |
J Nat Prod |
10.1021/np300505y |
2012 |
* |
Pathogenicity |
Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine. |
Burian A, Erdogan Z, Jandrisits C, Zeitlinger M |
Pharmacology |
10.1159/000342423 |
2012 |
* |
Pathogenicity |
Synthesis, characterization, and antimicrobial evaluation of some new hydrazinecarbothioamide, 1,2,4-triazole and 1,3,4-thiadiazole derivatives. |
Guzeldemirci NU, Satana D, Kucukbasmaci O |
J Enzyme Inhib Med Chem |
10.3109/14756366.2012.700926 |
2012 |
* |
Pathogenicity |
Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics. |
Ross JE, Sader HS, Ivezic-Schoenfeld Z, Paukner S, Jones RN |
J Clin Microbiol |
10.1128/JCM.01294-12 |
2012 |
* |
Pathogenicity |
Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs. |
Zhou Y, Hou Z, Fang C, Xue X, Da F, Wang Y, Bai H, Luo X |
Folia Microbiol (Praha) |
10.1007/s12223-012-0168-8 |
2012 |
* |
Pathogenicity |
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus. |
Tsuji BT, Brown T, Parasrampuria R, Brazeau DA, Forrest A, Kelchlin PA, Holden PN, Peloquin CA, Hanna D, Bulitta JB |
Antimicrob Agents Chemother |
10.1128/AAC.05453-11 |
2012 |
* |
Phenotype |
Classifying compound mechanism of action for linking whole cell phenotypes to molecular targets. |
Bourne CR, Wakeham N, Bunce RA, Nammalwar B, Berlin KD, Barrow WW |
J Mol Recognit |
10.1002/jmr.2174 |
2012 |
* |
Pathogenicity |
Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C. |
Masadeh MM, Mhaidat NM, Alzoubi KH, Al-Azzam SI, Shaweesh AI |
Curr Microbiol |
10.1007/s00284-012-0094-7 |
2012 |
* |
Metabolism |
[Effects of Staphylococcus aureus supernatant on expression of various cytokines by neutrophils and retinal pigment epithelium cells]. |
Lou BS, Yuan ZH, Luo YW, Lin XF |
Zhonghua Yan Ke Za Zhi |
|
2011 |
* |
Pathogenicity |
Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid. |
Schwameis R, Fille M, Manafi M, Zeitlinger M, Sauermann R |
Res Microbiol |
10.1016/j.resmic.2011.12.004 |
2011 |
* |
Pathogenicity |
Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression. |
Mitchell G, Lafrance M, Boulanger S, Seguin DL, Guay I, Gattuso M, Marsault E, Bouarab K, Malouin F |
J Antimicrob Chemother |
10.1093/jac/dkr510 |
2011 |
* |
Pathogenicity |
Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model. |
Rodriguez CA, Agudelo M, Zuluaga AF, Vesga O |
Antimicrob Agents Chemother |
10.1128/AAC.05129-11 |
2011 |
* |
Enzymology |
Antimicrobial effect of statins: organic solvents might falsify microbiological testing results. |
Matzneller P, Manafi M, Zeitlinger M |
Int J Clin Pharmacol Ther |
10.5414/cp201581 |
2011 |
* |
Phylogeny |
Lobophorins E and F, new spirotetronate antibiotics from a South China Sea-derived Streptomyces sp. SCSIO 01127. |
Niu S, Li S, Chen Y, Tian X, Zhang H, Zhang G, Zhang W, Yang X, Zhang S, Ju J, Zhang C |
J Antibiot (Tokyo) |
10.1038/ja.2011.78 |
2011 |
* |
Phylogeny |
Pseudonocardians A-C, new diazaanthraquinone derivatives from a deap-sea actinomycete Pseudonocardia sp. SCSIO 01299. |
Li S, Tian X, Niu S, Zhang W, Chen Y, Zhang H, Yang X, Zhang W, Li W, Zhang S, Ju J, Zhang C |
Mar Drugs |
10.3390/md9081428 |
2011 |
* |
Enzymology |
Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. |
Alt S, Mitchenall LA, Maxwell A, Heide L |
J Antimicrob Chemother |
10.1093/jac/dkr247 |
2011 |
* |
Pathogenicity |
Antibiofilm activity of selected plant essential oils and their major components. |
Budzynska A, Wieckowska-Szakiel M, Sadowska B, Kalemba D, Rozalska B |
Pol J Microbiol |
|
2011 |
* |
Pathogenicity |
Norfloxacin and ursolic acid: in vitro association and postantibiotic effect against Staphylococcus aureus. |
Filocamo A, Bisignano C, D'Arrigo M, Ginestra G, Mandalari G, Galati EM |
Lett Appl Microbiol |
10.1111/j.1472-765X.2011.03090.x |
2011 |
* |
Pathogenicity |
Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-beta-boswellic acid from Boswellia serrata. |
Raja AF, Ali F, Khan IA, Shawl AS, Arora DS, Shah BA, Taneja SC |
BMC Microbiol |
10.1186/1471-2180-11-54 |
2011 |
* |
Pathogenicity |
Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design. |
Bhagunde P, Singh R, Ledesma KR, Chang KT, Nikolaou M, Tam VH |
J Antimicrob Chemother |
10.1093/jac/dkr054 |
2011 |
* |
Pathogenicity |
Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. |
Sianglum W, Srimanote P, Wonglumsom W, Kittiniyom K, Voravuthikunchai SP |
PLoS One |
10.1371/journal.pone.0016628 |
2011 |
* |
Pathogenicity |
Synthesis of egonol derivatives and their antimicrobial activities. |
Emirdag-Ozturk S, Karayildirim T, Anil H |
Bioorg Med Chem |
10.1016/j.bmc.2010.12.044 |
2010 |
* |
Enzymology |
Prevalence of Staphylococcus aureus and lack of its lytic bacteriophages in the anterior nares of patients and healthcare workers at a rural clinic. |
Aswani VH, Shukla SK |
Clin Med Res |
10.3121/cmr.2010.954 |
2010 |
* |
Pathogenicity |
Self-protecting bactericidal titanium alloy surface formed by covalent bonding of daptomycin bisphosphonates. |
Chen CP, Wickstrom E |
Bioconjug Chem |
10.1021/bc100136e |
2010 |
* |
Pathogenicity |
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus. |
Croes S, Beisser PS, Terporten PH, Neef C, Deurenberg RH, Stobberingh EE |
Clin Microbiol Infect |
10.1111/j.1469-0691.2010.02956.x |
2010 |
* |
Pathogenicity |
Multistep virtual screening for rapid and efficient identification of non-nucleoside bacterial thymidine kinase inhibitors. |
Zander J, Hartenfeller M, Hahnke V, Proschak E, Besier S, Wichelhaus TA, Schneider G |
Chemistry |
10.1002/chem.201001347 |
2010 |
* |
Pathogenicity |
Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution. |
Gonzalez R, Albericio F, Cascone O, Iannucci NB |
J Pept Sci |
10.1002/psc.1258 |
2010 |
* |
Pathogenicity |
MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study. |
Singh R, Ray P, Das A, Sharma M |
Microsc Res Tech |
10.1002/jemt.20871 |
2010 |
* |
Pathogenicity |
Antimicrobial properties of prunin, a citric flavanone glucoside, and its prunin 6''-O-lauroyl ester. |
Celiz G, Audisio MC, Daz M |
J Appl Microbiol |
10.1111/j.1365-2672.2010.04773.x |
2010 |
* |
Pathogenicity |
Revealing fosfomycin primary effect on Staphylococcus aureus transcriptome: modulation of cell envelope biosynthesis and phosphoenolpyruvate induced starvation. |
Petek M, Baebler S, Kuzman D, Rotter A, Podlesek Z, Gruden K, Ravnikar M, Urleb U |
BMC Microbiol |
10.1186/1471-2180-10-159 |
2010 |
* |
Pathogenicity |
Functional and ultrastructural changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Cinnamomum verum essential oil. |
Bouhdid S, Abrini J, Amensour M, Zhiri A, Espuny MJ, Manresa A |
J Appl Microbiol |
10.1111/j.1365-2672.2010.04740.x |
2010 |
* |
Pathogenicity |
Synthesis and antimicrobial activity of novel Ag-N-hetero-cyclic carbene complexes. |
Ozdemir I, Ozcan EO, Gunal S, Gurbuz N |
Molecules |
10.3390/molecules15042499 |
2010 |
* |
Pathogenicity |
Biofilm formation on bone grafts and bone graft substitutes: comparison of different materials by a standard in vitro test and microcalorimetry. |
Clauss M, Trampuz A, Borens O, Bohner M, Ilchmann T |
Acta Biomater |
10.1016/j.actbio.2010.03.011 |
2010 |
* |
Pathogenicity |
[Investigation of antibacterial activity of sertralin]. |
Coban AY, Tanriverdi Cayci Y, Keles Uludag S, Durupinar B |
Mikrobiyol Bul |
|
2009 |
* |
Pathogenicity |
Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones. |
Tomasic T, Zidar N, Mueller-Premru M, Kikelj D, Masic LP |
Eur J Med Chem |
10.1016/j.ejmech.2009.12.030 |
2009 |
* |
Pathogenicity |
In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey. |
Erdogan H, Can F, Demirbilek M, Timurkaynak F, Arslan H |
Environ Monit Assess |
10.1007/s10661-009-1293-y |
2010 |
* |
Metabolism |
Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus. |
Paez PL, Becerra MC, Albesa I |
FEMS Microbiol Lett |
10.1111/j.1574-6968.2009.01867.x |
2009 |
* |
Pathogenicity |
Benzoxazine series of histidine kinase inhibitors as potential antimicrobial agents with activity against enterococci. |
Mueller-Premru M, Zidar N, Spik VC, Krope A, Kikelj D |
Chemotherapy |
10.1159/000263228 |
2009 |
* |
Pathogenicity |
Relationship between structure and antibacterial activity of lipophilic N-acyldiamines. |
de Almeida CG, Garbois GD, Amaral LM, Diniz CC, Le Hyaric M |
Biomed Pharmacother |
10.1016/j.biopha.2009.09.013 |
2009 |
* |
Enzymology |
Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus. |
Joukhadar C, Pillai S, Wennersten C, Moellering RC Jr, Eliopoulos GM |
Antimicrob Agents Chemother |
10.1128/AAC.00348-09 |
2009 |
* |
Metabolism |
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms. |
Di Stefano A, D'Aurizio E, Trubiani O, Grande R, Di Campli E, Di Giulio M, Di Bartolomeo S, Sozio P, Iannitelli A, Nostro A, Cellini L |
Microb Biotechnol |
10.1111/j.1751-7915.2009.00120.x |
2009 |
* |
Pathogenicity |
Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms. |
Pettit RK, Weber CA, Pettit GR |
Ann Clin Microbiol Antimicrob |
10.1186/1476-0711-8-28 |
2009 |
* |
Pathogenicity |
Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). |
Locke JB, Hilgers M, Shaw KJ |
Antimicrob Agents Chemother |
10.1128/AAC.00871-09 |
2009 |
* |
Pathogenicity |
Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli. |
D'Arrigo M, Ginestra G, Mandalari G, Furneri PM, Bisignano G |
Phytomedicine |
10.1016/j.phymed.2009.07.008 |
2009 |
* |
Cultivation |
Comparative evaluation of a rapid MRSA detection assay based on multiplex real-time PCR versus MRSA screening cultures containing egg yolk. |
Sumitani Y, Kobayashi Y |
J Infect Chemother |
10.1007/s10156-009-0685-9 |
2009 |
* |
Pathogenicity |
Ceanothane and lupane type triterpenes from Zizyphus joazeiro - an anti-staphylococcal evaluation. |
Leal IC, dos Santos KR, Junior II, Antunes OA, Porzel A, Wessjohann L, Kuster RM |
Planta Med |
10.1055/s-0029-1185947 |
2009 |
* |
Pathogenicity |
Antimicrobial and antistaphylococcal biofilm activity from the sea urchin Paracentrotus lividus. |
Schillaci D, Arizza V, Parrinello N, Di Stefano V, Fanara S, Muccilli V, Cunsolo V, Haagensen JJ, Molin S |
J Appl Microbiol |
10.1111/j.1365-2672.2009.04394.x |
2010 |
* |
Pathogenicity |
Synthesis, antibacterial and antifungal activities of novel 1,2,4-triazolium derivatives. |
Luo Y, Lu YH, Gan LL, Zhou CH, Wu J, Geng RX, Zhang YY |
Arch Pharm (Weinheim) |
10.1002/ardp.200800221 |
2009 |
* |
Pathogenicity |
Anti-adhesion activity of two biosurfactants produced by Bacillus spp. prevents biofilm formation of human bacterial pathogens. |
Rivardo F, Turner RJ, Allegrone G, Ceri H, Martinotti MG |
Appl Microbiol Biotechnol |
10.1007/s00253-009-1987-7 |
2009 |
* |
Pathogenicity |
Investigation of functional and morphological changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Origanum compactum essential oil. |
Bouhdid S, Abrini J, Zhiri A, Espuny MJ, Manresa A |
J Appl Microbiol |
10.1111/j.1365-2672.2008.04124.x |
2009 |
* |
Pathogenicity |
In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils. |
Schillaci D, Arizza V, Dayton T, Camarda L, Di Stefano V |
Lett Appl Microbiol |
10.1111/j.1472-765X.2008.02469.x |
2008 |
* |
Pathogenicity |
Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. |
Belley A, Neesham-Grenon E, McKay G, Arhin FF, Harris R, Beveridge T, Parr TR Jr, Moeck G |
Antimicrob Agents Chemother |
10.1128/AAC.00766-08 |
2008 |
* |
Pathogenicity |
Antibacterial effects of three experimental quaternary ammonium salt (QAS) monomers on bacteria associated with oral infections. |
Xiao YH, Chen JH, Fang M, Xing XD, Wang H, Wang YJ, Li F |
J Oral Sci |
10.2334/josnusd.50.323 |
2008 |
* |
Pathogenicity |
Antimicrobial activity of some sulfonamide derivatives on clinical isolates of Staphylococus aureus. |
Genc Y, Ozkanca R, Bekdemir Y |
Ann Clin Microbiol Antimicrob |
10.1186/1476-0711-7-17 |
2008 |
* |
Pathogenicity |
Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters. |
Arhin FF, Tomfohrde K, Draghi DC, Aranza M, Parr TR Jr, Sahm DF, Moeck G |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2008.05.009 |
2008 |
* |
Pathogenicity |
Comparison of agar dilution and E-test for antimicrobial susceptibility testing of Campylobacter coil isolates recovered from 80 Ontario swine farms. |
Varela NP, Friendship R, Dewey C, Valdivieso A |
Can J Vet Res |
|
2008 |
* |
Pathogenicity |
Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. |
Ryge TS, Frimodt-Moller N, Hansen PR |
Chemotherapy |
10.1159/000119707 |
2008 |
* |
Pathogenicity |
Effect of tumor necrosis factor-alpha on intracellular Staphylococcus aureus in vascular endothelial cells. |
Park WB, Lee JH, Jeon JH, Lee SJ, Kim SH, Kim NJ, Kim HB, Oh MD, Choe KW |
FEMS Immunol Med Microbiol |
10.1111/j.1574-695X.2007.00365.x |
2008 |
* |
Enzymology |
[Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA]. |
Nagasawa Z, Nakashima Y, Oho M, Kusaba K, Manome I, Nagayama A |
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi |
|
2008 |
* |
Pathogenicity |
[Influence of doxorubicin on the development of resistance of staphylococci to ceftriaxone]. |
Shapoval OG |
Zh Mikrobiol Epidemiol Immunobiol |
|
2007 |
* |
Pathogenicity |
Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus. |
Hegde SS, Reyes N, Skinner R, Difuntorum S |
J Antimicrob Chemother |
10.1093/jac/dkm417 |
2007 |
* |
Pathogenicity |
In vitro ability of Staphylococcus aureus isolates from bacteraemic patients with and without metastatic complications to invade vascular endothelial cells. |
Park WB, Kim SH, Kang CI, Cho JH, Bang JW, Park KW, Lee YS, Kim NJ, Oh MD, Kim HB, Won Choe K |
J Med Microbiol |
10.1099/jmm.0.46765-0 |
2007 |
* |
Enzymology |
[Species-identification and antimicrobial susceptibility tests by the fully automated RAISUS using an early-harvested cell suspension]. |
Nakasone I, Kisanuki K, Higa M, Kinjo T, Yamane N |
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi |
|
2006 |
* |
Pathogenicity |
Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent. |
Rennie RP, Koeth L, Jones RN, Fritsche TR, Knapp CC, Killian SB, Goldstein BP |
J Clin Microbiol |
10.1128/JCM.02411-06 |
2007 |
* |
Enzymology |
Antimicrobial compounds from Eremophila serrulata. |
Ndi CP, Semple SJ, Griesser HJ, Pyke SM, Barton MD |
Phytochemistry |
10.1016/j.phytochem.2007.05.039 |
2007 |
* |
Enzymology |
Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. |
Trampuz A, Murphy CK, Rothstein DM, Widmer AF, Landmann R, Zimmerli W |
Antimicrob Agents Chemother |
10.1128/AAC.00120-07 |
2007 |
* |
Pathogenicity |
Antibiotic susceptibility of potentially probiotic vaginal lactobacilli. |
Ocana V, Silva C, Nader-Macias ME |
Infect Dis Obstet Gynecol |
10.1155/IDOG/2006/18182 |
2006 |
* |
Pathogenicity |
Identification of antibacterial constituents from the indigenous Australian medicinal plant Eremophila duttonii F. Muell. (Myoporaceae). |
Smith JE, Tucker D, Watson K, Jones GL |
J Ethnopharmacol |
10.1016/j.jep.2007.03.031 |
2007 |
* |
Pathogenicity |
[Investigation of the efficacy of electrolyzed acid water on the standard strains of some pathogenic microorganisms]. |
Ileri C, Sezen Y, Dimoglo A |
Mikrobiyol Bul |
|
2006 |
* |
Pathogenicity |
Bismuth-norfloxacin complex: synthesis, physicochemical and antimicrobial evaluation. |
Shaikh AR, Giridhar R, Yadav MR |
Int J Pharm |
10.1016/j.ijpharm.2006.11.037 |
2006 |
* |
Pathogenicity |
Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species. |
DeRyke CA, Sutherland C, Zhang B, Nicolau DP, Kuti JL |
Antimicrob Agents Chemother |
10.1128/AAC.00290-06 |
2006 |
* |
Pathogenicity |
Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. |
Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA |
Antimicrob Agents Chemother |
10.1128/AAC.01165-05 |
2006 |
* |
Enzymology |
Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats. |
Kalteis T, Beckmann J, Schroder HJ, Handel M, Grifka J, Lehn N, Lerch K |
Acta Orthop |
10.1080/17453670610046082 |
2006 |
* |
Pathogenicity |
Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM). |
Schafer JA, Hovde LB, Rotschafer JC |
J Antimicrob Chemother |
10.1093/jac/dkl216 |
2006 |
* |
Pathogenicity |
Antibacterial activities of inorganic agents on six bacteria associated with oral infections by two susceptibility tests. |
Fang M, Chen JH, Xu XL, Yang PH, Hildebrand HF |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2006.01.008 |
2006 |
* |
Pathogenicity |
Treatment of implant-associated infections with moxifloxacin: an animal study. |
Kalteis T, Beckmann J, Schroder HJ, Schaumburger J, Linde HJ, Lerch K, Lehn N |
Int J Antimicrob Agents |
10.1016/j.ijantimicag.2005.12.003 |
2006 |
* |
Enzymology |
Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target. |
Andes D, Craig WA |
Antimicrob Agents Chemother |
10.1128/AAC.50.4.1376-1383.2006 |
2006 |
* |
Pathogenicity |
Lipids and DNA oxidation in Staphylococcus aureus as a consequence of oxidative stress generated by ciprofloxacin. |
Becerra MC, Paez PL, Larovere LE, Albesa I |
Mol Cell Biochem |
10.1007/s11010-005-9051-0 |
2006 |
* |
Enzymology |
Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models. |
Andes D, Craig WA |
Antimicrob Agents Chemother |
10.1128/AAC.50.1.243-249.2006 |
2006 |
* |
Enzymology |
Analysis of the beta-lactamase plasmid of borderline methicillin-susceptible Staphylococcus aureus: focus on bla complex genes and cadmium resistance determinants cadD and cadX. |
Massidda O, Mingoia M, Fadda D, Whalen MB, Montanari MP, Varaldo PE |
Plasmid |
10.1016/j.plasmid.2005.08.001 |
2005 |
* |
Pathogenicity |
Synthesis and evaluation of analgesic/ anti-inflammatory and antimicrobial activities of 3-substituted- 1,2,4-triazole-5-thiones. |
Tozkoparan B, Kupeli E, Yesilada E, Isik S, Ozalp M, Ertan M |
Arzneimittelforschung |
10.1055/s-0031-1296901 |
2005 |
* |
Pathogenicity |
Flow cytometry analysis of the activity of disinfecting agents tested with Staphylococcus aureus and Escherichia coli. |
Wozniak-Kosek A, Kawiak J |
Pol J Microbiol |
|
2005 |
* |
Pathogenicity |
Cationic peptide of the male reproductive tract, HE2alpha, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. |
Liao M, Ruddock PS, Rizvi AS, Hall SH, French FS, Dillon JR |
J Antimicrob Chemother |
10.1093/jac/dki350 |
2005 |
* |
Enzymology |
The effect of interlaboratory variability on antimicrobial susceptibility determination. |
Annis DH, Craig BA |
Diagn Microbiol Infect Dis |
10.1016/j.diagmicrobio.2005.03.012 |
2005 |
* |
Pathogenicity |
[Impact of Ph-SA on the expression of delta-toxin in Staphylococcus aureus]. |
Guo L, Zhang J, Tang XY, Qiu XQ |
Sichuan Da Xue Xue Bao Yi Xue Ban |
|
2005 |
* |
Pathogenicity |
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities. |
Liang CH, Romero A, Rabuka D, Sgarbi PW, Marby KA, Duffield J, Yao S, Cheng ML, Ichikawa Y, Sears P, Hu C, Hwang SB, Shue YK, Sucheck SJ |
Bioorg Med Chem Lett |
10.1016/j.bmcl.2005.02.029 |
2005 |
* |
Pathogenicity |
Identification of novel inhibitors of bacterial translation elongation factors. |
Jayasekera MM, Onheiber K, Keith J, Venkatesan H, Santillan A, Stocking EM, Tang L, Miller J, Gomez L, Rhead B, Delcamp T, Huang S, Wolin R, Bobkova EV, Shaw KJ |
Antimicrob Agents Chemother |
10.1128/AAC.49.1.131-136.2005 |
2005 |
* |
Pathogenicity |
Biofilm susceptibility to metal toxicity. |
Harrison JJ, Ceri H, Stremick CA, Turner RJ |
Environ Microbiol |
10.1111/j.1462-2920.2004.00656.x |
2004 |
* |
Metabolism |
Light effect and reactive oxygen species in the action of ciprofloxacin on Staphylococcus aureus. |
Becerra MC, Sarmiento M, Paez PL, Arguello G, Albesa I |
J Photochem Photobiol B |
10.1016/j.jphotobiol.2004.06.003 |
2004 |
* |
Metabolism |
Impact of plasma protein binding on antimicrobial activity using time-killing curves. |
Zeitlinger MA, Sauermann R, Traunmuller F, Georgopoulos A, Muller M, Joukhadar C |
J Antimicrob Chemother |
10.1093/jac/dkh443 |
2004 |
* |
Pathogenicity |
Synthesis and characterization of human alpha-defensins 4-6. |
Wu Z, Ericksen B, Tucker K, Lubkowski J, Lu W |
J Pept Res |
10.1111/j.1399-3011.2004.00179.x |
2004 |
* |
Pathogenicity |
Comparison of methods for antimicrobial susceptibility testing and MIC values for pleuromutilin drugs for Brachyspira hyodysenteriae isolated in Germany. |
Rohde J, Kessler M, Baums CG, Amtsberg G |
Vet Microbiol |
10.1016/j.vetmic.2004.03.023 |
2004 |
* |
Metabolism |
Differences in biofilm and planktonic cell mediated reduction of metalloid oxyanions. |
Harrison JJ, Ceri H, Stremick C, Turner RJ |
FEMS Microbiol Lett |
10.1016/j.femsle.2004.05.005 |
2004 |
* |
Enzymology |
In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections. |
Ganiere JP, Medaille C, Etore F |
Res Vet Sci |
10.1016/j.rvsc.2004.02.002 |
2004 |
* |
Cultivation |
Synthesis and antibacterial activities of new bis-benzimidazoles. |
Kucukbay H, Durmaz R, Okuyucu N, Gunal S, Kazaz C |
Arzneimittelforschung |
10.1055/s-0031-1296938 |
2004 |
* |
Pathogenicity |
Bacterial reduction by cell salvage washing and leukocyte depletion filtration. |
Waters JH, Tuohy MJ, Hobson DF, Procop G |
Anesthesiology |
10.1097/00000542-200309000-00021 |
2003 |
* |
Pathogenicity |
Inhibition of the anti-staphylococcal activity of the antiseptic polihexanide by mucin. |
Ansorg R, Rath PM, Fabry W |
Arzneimittelforschung |
10.1055/s-0031-1297121 |
2003 |
* |
Enzymology |
Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. |
Zeitlinger MA, Marsik C, Georgopoulos A, Muller M, Heinz G, Joukhadar C |
Int J Antimicrob Agents |
10.1016/s0924-8579(03)00047-5 |
2003 |
* |
Pathogenicity |
Calibration of fusidic acid disk diffusion susceptibility testing of Staphylococcus areus. |
Olsson-Liljequist B, Koljalg S, Karlsson I, Kronvall G |
APMIS |
10.1034/j.1600-0463.2002.1101002.x |
2002 |
* |
Pathogenicity |
The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. |
Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J |
J Biol Chem |
10.1074/jbc.M203907200 |
2002 |
* |
Pathogenicity |
Remarkable substituent effects on antimicrobial activities of 1,3-diorganylimidazolidinium salts. |
Cetinkaya E, Denizci A, Ozdemir I, Ozturk HT, Karaboz I, Cetinkaya B |
J Chemother |
10.1179/joc.2002.14.3.241 |
2002 |
* |
Phylogeny |
Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. |
Bernardo K, Pakulat N, Macht M, Krut O, Seifert H, Fleer S, Hunger F, Kronke M |
Proteomics |
10.1002/1615-9861(200206)2:6<747::AID-PROT747>3.0.CO;2-V |
2002 |
* |
Pathogenicity |
In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. |
Yorganci K, Krepel C, Weigelt JA, Edmiston CE |
Eur J Clin Microbiol Infect Dis |
10.1007/s10096-002-0719-z |
2002 |
* |
Pathogenicity |
Inhibition, resistance development, and increased antibiotic and antimicrobial resistance caused by nutraceuticals. |
Ward P, Fasitsas S, Katz SE |
J Food Prot |
10.4315/0362-028x-65.3.528 |
2002 |
* |
Pathogenicity |
Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis. |
Yanyali A, Cetin S, Talu H, Vahaboglu H |
Ophthalmologica |
10.1159/000050905 |
2001 |
* |
Pathogenicity |
Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001). |
Jones RN, Biedenbach DJ |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(01)00236-x |
2001 |
* |
Pathogenicity |
Synthesis of some benzimidazole derivatives and their antibacterial and antifungal activities. |
Kucukbay H, Durmaz R, Guven M, Gunal S |
Arzneimittelforschung |
10.1055/s-0031-1300057 |
2001 |
* |
Pathogenicity |
[Experimental study of antiseptic (tauroline, taurolidine) and antibiotic (sulmycin implant) drugs in vascular prosthesis infections in a standardized infection model]. |
Hernandez-Richter T, Schardey HM, Heiss MM, Lohlein F, Schildberg FW |
Zentralbl Chir |
10.1055/s-2001-14758 |
2001 |
* |
Pathogenicity |
Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar. |
Dominguez MC, de La Rosa M, Borobio MV |
J Antimicrob Chemother |
10.1093/jac/47.4.391 |
2001 |
* |
Pathogenicity |
Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis. |
White RL, Friedrich LV, Manduru M, Mihm LB, Bosso JA |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(00)00219-4 |
2001 |
* |
Metabolism |
In vivo metabolism of 4-fluorobenzoic acid [(5-nitro-2-furanyl)methylene] hydrazide in rats. |
Gulerman NN, Oruc EE, Kartal F, Rollas S |
Eur J Drug Metab Pharmacokinet |
10.1007/BF03190075 |
2000 |
* |
Pathogenicity |
Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. |
Todisco T, Eslami A, Baglioni S, Sposini T, Tascini C, Sommer E, Knoch M |
J Aerosol Med |
10.1089/jam.2000.13.11 |
2000 |
* |
Cultivation |
Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media. |
Marshall SA, Kugler KC, Jones RN |
Int J Antimicrob Agents |
10.1016/s0924-8579(00)00180-1 |
2000 |
* |
Pathogenicity |
Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa. |
Smith RP, Baltch AL, Franke MA, Michelsen PB, Bopp LH |
J Antimicrob Chemother |
10.1093/jac/45.4.483 |
2000 |
* |
Pathogenicity |
Antimicrobial activity of synthetic all-D mastoparan M. |
Li ML, Liao RW, Qiu JW, Wang ZJ, Wu TM |
Int J Antimicrob Agents |
10.1016/s0924-8579(99)00127-2 |
2000 |
* |
Pathogenicity |
Staphylococcus aureus adherence to thrombin-treated endothelial cells is mediated by fibrinogen but not by platelets. |
Shenkman B, Rubinstein E, Tamarin I, Dardik R, Savion N, Varon D |
J Lab Clin Med |
10.1016/s0022-2143(00)70019-9 |
2000 |
* |
Pathogenicity |
Decontamination of human sclera: an in vitro study. |
Lucci LM, Yu MC, Hofling-Lima AL |
Cornea |
00003226-199909000-00011 |
1999 |
* |
Pathogenicity |
Antibacterial and antifungal activities of complexes of ruthenium (II). |
Cetinkaya B, Ozdemir I, Binbasioglu B, Durmaz R, Gunal S |
Arzneimittelforschung |
10.1055/s-0031-1300457 |
1999 |
* |
Pathogenicity |
Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality Control Study Group. |
Jones RN, Marshall SA, Erwin ME |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(98)00093-5 |
1999 |
* |
Pathogenicity |
In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens. |
Schwab U, Gilligan P, Jaynes J, Henke D |
Antimicrob Agents Chemother |
10.1128/AAC.43.6.1435 |
1999 |
* |
Pathogenicity |
New derivatives of benzimidazole and their antimicrobial activity. |
Cetinkaya E, Alici B, Gok Y, Durmaz R, Gunal S |
J Chemother |
10.1179/joc.1999.11.2.83 |
1999 |
* |
Pathogenicity |
The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. |
Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A |
J Clin Microbiol |
10.1128/JCM.37.6.1771-1776.1999 |
1999 |
* |
Enzymology |
Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess. |
Fernandez J, Barrett JF, Licata L, Amaratunga D, Frosco M |
Antimicrob Agents Chemother |
10.1128/AAC.43.3.667 |
1999 |
* |
Pathogenicity |
Antibacterial activity of peritoneal exudate in patients treated with 2 g cefotiam for surgical anti-microbial prophylaxis. |
Miglioli PA, Schoeffel U, Gabroska E, Allerberger F |
Chemotherapy |
10.1159/000007108 |
1998 |
* |
Pathogenicity |
Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. |
Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, O'Hara CM, McAllister SK, Clark NC, Hiramatsu K |
J Clin Microbiol |
10.1128/JCM.36.4.1020-1027.1998 |
1998 |
* |
Pathogenicity |
Antibacterial activity of rhodium, iridium, and ruthenium tripodal phosphine complexes. |
Sulu M, Kucukbay H, Durmaz R, Gunal S |
Arzneimittelforschung |
|
1998 |
* |
Enzymology |
A novel variant of staphylokinase gene from Staphylococcus aureus ATCC 29213. |
Kim SH, Chun HS, Han MH, Park NY, Suk K |
Thromb Res |
10.1016/s0049-3848(97)00142-4 |
1997 |
* |
Pathogenicity |
Synthesis and antimicrobial activities of 2-[(alpha-methylbenzylidene)-hydrazino]benzoxazoles. |
Ersan S, Nacak S, Berkem R, Ozden T |
Arzneimittelforschung |
|
1997 |
* |
Phylogeny |
In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/RPR106950): a novel orally administered streptogramin combination. The Quality Control Study Group. |
Putnam SD, Jones RN, Johnson DM |
Diagn Microbiol Infect Dis |
10.1016/s0732-8893(97)00023-0 |
1997 |
* |
Pathogenicity |
Does tea tree oil have a place in the topical treatment of burns? |
Faoagali J, George N, Leditschke JF |
Burns |
10.1016/s0305-4179(96)00130-1 |
1997 |
* |
Pathogenicity |
Synthesis and antimicrobial activity of beta-[(2-benzimidazolyl)thio]-beta-benzoyl styrene derivatives. |
Ersan S, Nacak S, Acar N, Ozden T |
Arzneimittelforschung |
|
1997 |
* |
Pathogenicity |
Synthesis and antimicrobial activity of 1-dialkylaminomethyl- 2-(p-substituted phenyl)-5-substituted benzimidazole derivatives. |
Ersan S, Nacak S, Acar N, Noyanalpan N |
Arzneimittelforschung |
|
1997 |
* |
Pathogenicity |
Synthesis and antimicrobial activity of electron rich olefin derived cyclic ureas. |
Cetinkaya B, Cetinkaya E, Kucukbay H, Durmaz R |
Arzneimittelforschung |
|
1996 |
* |
Enzymology |
The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditions. |
Larsson AJ, Walker KJ, Raddatz JK, Rotschafer JC |
J Antimicrob Chemother |
10.1093/jac/38.4.589 |
1996 |
* |
Pathogenicity |
Antimicrobial activity of carbene complexes of rhodium(I) and ruthenium(II). |
Cetinkaya B, Cetinkaya E, Kucukbay H, Durmaz R |
Arzneimittelforschung |
|
1996 |
* |
Pathogenicity |
Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. |
White RL, Burgess DS, Manduru M, Bosso JA |
Antimicrob Agents Chemother |
10.1128/AAC.40.8.1914 |
1996 |
* |
Pathogenicity |
Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin. |
Marshall SA, Jones RN, Wanger A, Washington JA, Doern GV, Leber AL, Haugen TH |
J Clin Microbiol |
10.1128/jcm.34.8.2027-2029.1996 |
1996 |
* |
Pathogenicity |
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. |
Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ |
Antimicrob Agents Chemother |
10.1128/AAC.40.4.839 |
1996 |
* |
Enzymology |
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers. |
Aguilar L, Balcabao IP, Salva P, Martin M, Costa J, Prieto J, Dal-re R |
Antimicrob Agents Chemother |
10.1128/AAC.40.1.17 |
1996 |
* |
Pathogenicity |
Synthesis and antimicrobial activity of substituted benzimidazole, benzothiazole and imidazole derivatives. |
Kucukbay H, Cetinkaya E, Durmaz R |
Arzneimittelforschung |
|
1995 |
* |
Pathogenicity |
Synthesis and antibacterial activity of some novel 1-substituted 1,4-dihydro-4-oxo-7-pyridinyl-3-quinolinecarboxylic acids. Potent antistaphylococcal agents. |
Reuman M, Daum SJ, Singh B, Wentland MP, Perni RB, Pennock P, Carabateas PM, Gruett MD, Saindane MT, Dorff PH, et al. |
J Med Chem |
10.1021/jm00014a005 |
1995 |
* |
Enzymology |
Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones. |
Zabinski RA, Walker KJ, Larsson AJ, Moody JA, Kaatz GW, Rotschafer JC |
Antimicrob Agents Chemother |
10.1128/AAC.39.2.507 |
1995 |
* |
Metabolism |
The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. |
Conly JM, Stein K, Worobetz L, Rutledge-Harding S |
Am J Gastroenterol |
|
1994 |
* |
Enzymology |
Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. |
Zimmerli W, Frei R, Widmer AF, Rajacic Z |
J Antimicrob Chemother |
10.1093/jac/33.5.959 |
1994 |
* |
Pathogenicity |
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group. |
Bale MJ, Jones RN, Erwin ME |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(94)90054-x |
1994 |
* |
Enzymology |
Separation and isolation of viable bacteria by capillary zone electrophoresis. |
Ebersole RC, McCormick RM |
Biotechnology (N Y) |
10.1038/nbt1193-1278 |
1993 |
* |
Pathogenicity |
The inhibition by ionophores in vitro of an Enterococcus-like pathogen of rainbow trout, Oncorhynchus mykiss. |
Carson J, Statham P |
Vet Microbiol |
10.1016/0378-1135(93)90092-l |
1993 |
* |
Pathogenicity |
Production of staphylococcal impetigo-like lesion on human skin explants in culture. |
Abe Y, Akiyama H, Arata J |
J Dermatol Sci |
10.1016/0923-1811(93)90762-e |
1993 |
* |
Metabolism |
Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. |
McCaffrey C, Bertasso A, Pace J, Georgopapadakou NH |
Antimicrob Agents Chemother |
10.1128/AAC.36.8.1601 |
1992 |
* |
Pathogenicity |
Improved method for electroporation of Staphylococcus aureus. |
Schenk S, Laddaga RA |
FEMS Microbiol Lett |
10.1016/0378-1097(92)90596-g |
1992 |
* |
Pathogenicity |
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates. |
Murray PR, Allen SD, Erwin ME, Gerlach EH, Jones RN, Koontz FP, Pfaller MA, Washington JA 2nd |
Eur J Clin Microbiol Infect Dis |
10.1007/BF01972510 |
1991 |
* |
Pathogenicity |
Interpretive criteria for disk diffusion susceptibility testing of sparfloxacin. |
Kayser FH, Wust J |
Eur J Clin Microbiol Infect Dis |
10.1007/BF01964449 |
1991 |
* |
Pathogenicity |
In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. |
Fass RJ |
Antimicrob Agents Chemother |
10.1128/AAC.35.3.553 |
1991 |
* |
Pathogenicity |
In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci. |
Varotto F, Garlaschi ML, Garlaschi MC, Falchi M, Scaglione F, Cattaneo G, De Luca M, Fraschini F |
J Chemother |
10.1080/1120009x.1990.11739043 |
1990 |
* |
Pathogenicity |
Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria. |
Fuchs PC, Jones RN, Barry AL, Gavan TL |
J Clin Microbiol |
10.1128/jcm.27.1.49-52.1989 |
1989 |
* |
Pathogenicity |
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101. |
Barry AL, Aldridge KE, Allen SD, Fuchs PC, Gerlach EH, Jones RN, Pfaller MA |
Eur J Clin Microbiol Infect Dis |
10.1007/BF01975053 |
1988 |
* |
Pathogenicity |
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control. |
Jones RN, Barry AL, Pfaller M, Allen SD, Ayers LW, Fuchs PC |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(88)90063-6 |
1988 |
* |
Pathogenicity |
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin. |
Jones RN, Barry AL |
J Clin Microbiol |
10.1128/jcm.25.11.2211-2213.1987 |
1987 |
* |
Pathogenicity |
Quality control limits for microdilution susceptibility tests with norfloxacin. |
Barry AL, Gavan TL, Ayers LW, Fuchs PC, Gerlach EH, Thornsberry C |
J Clin Microbiol |
10.1128/jcm.25.1.165-166.1987 |
1987 |
* |
Pathogenicity |
In Vitro Influence of ZnO, CrZnO, RuZnO, and BaZnO Nanomaterials on Bacterial Growth. |
Abdallah EM, Modwi A, Al-Mijalli SH, Mohammed AE, Idriss H, Omar AS, Afifi M, Al-Farga A, Goh KW, Ming LC |
Molecules |
10.3390/molecules27238309 |
2022 |
* |
Pathogenicity |
Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial Infections. |
Strharsky T, Pindjakova D, Kos J, Vrablova L, Smak P, Michnova H, Gonec T, Hosek J, Oravec M, Jendrzejewska I, Cizek A, Jampilek J |
Int J Mol Sci |
10.3390/ijms232315090 |
2022 |
* |
Pathogenicity |
Design, Synthesis and Antimicrobial Properties of New Tetracyclic Quinobenzothiazine Derivatives. |
Kisiel-Nawrot E, Pindjakova D, Latocha M, Bak A, Kozik V, Suwinska K, Sochanik A, Cizek A, Jampilek J, Zieba A |
Int J Mol Sci |
10.3390/ijms232315078 |
2022 |
* |
Pathogenicity |
Study of Biological Activities and ADMET-Related Properties of Salicylanilide-Based Peptidomimetics. |
Pindjakova D, Pilarova E, Pauk K, Michnova H, Hosek J, Magar P, Cizek A, Imramovsky A, Jampilek J |
Int J Mol Sci |
10.3390/ijms231911648 |
2022 |
* |
Metabolism |
Prenylated notoamide-type alkaloids isolated from the fungus Aspergillus sclerotiorum and their inhibition of NLRP3 inflammasome activation and antibacterial activities. |
Meng Q, Guo X, Wu J, Liu D, Gu Y, Huang J, Fan A, Lin W |
Phytochemistry |
10.1016/j.phytochem.2022.113424 |
2022 |
* |
Phylogeny |
Isolation and Identification of Flavones Responsible for the Antibacterial Activities of Tillandsia bergeri Extracts. |
Lo MM, Benfodda Z, Dunyach-Remy C, Benimelis D, Roulard R, Fontaine JX, Mathiron D, Quero A, Molinie R, Meffre P |
ACS Omega |
10.1021/acsomega.2c04195 |
2022 |
* |
Pathogenicity |
Design, synthesis, and biological evaluation of tetrahydroquinoline amphiphiles as membrane-targeting antimicrobials against pathogenic bacteria and fungi. |
Liu J, Li H, He Q, Chen K, Chen Y, Zhong R, Li H, Fang S, Liu S, Lin S |
Eur J Med Chem |
10.1016/j.ejmech.2022.114734 |
2022 |
* |
Pathogenicity |
Design, synthesis, and antibacterial activity of derivatives of Tryptophanyl-tRNA synthetase inhibitor indolmycin. |
Sun L, Zhang S, Kou S, Yi H, Cui A, Li Z |
Eur J Med Chem |
10.1016/j.ejmech.2022.114647 |
2022 |
* |
Phylogeny |
iChip-Inspired Isolation, Bioactivities and Dereplication of Actinomycetota from Portuguese Beach Sediments. |
Dos Santos JDN, Joao SA, Martin J, Vicente F, Reyes F, Lage OM |
Microorganisms |
10.3390/microorganisms10071471 |
2022 |
* |
|
Effect of five decontamination methods on face masks and filtering facepiece respirators contaminated with Staphylococcus aureus and Pseudomonas aeruginosa. |
Martinez E, Crevecoeur S, Dams L, Rabecki F, Habraken S, Haubruge E, Daube G |
Access Microbiol |
10.1099/acmi.0.000342 |
2022 |
* |
|
Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents. |
Chai F, Wang J, Zhou KX, Wang SK, Liu YH, Jin Z, Tang YZ |
Bioorg Chem |
10.1016/j.bioorg.2022.105859 |
2022 |
* |
|
Antibiofilm and cytotoxic potential of extracellular biosynthesized gold nanoparticles using actinobacteria Amycolatopsis sp. KMN. |
Kabiri F, Aghaei SS, Pourbabaee AA, Soleimani M, Komeili Movahhed T |
Prep Biochem Biotechnol |
10.1080/10826068.2022.2076244 |
2022 |
* |
|
Inhibitory Effect of Andrographis paniculata Lactone on Staphylococcus aureus alpha-Hemolysin. |
Wang X, Ma Q, Niu X, Liu Z, Kang X, Mao Y, Li N, Wang G |
Front Pharmacol |
10.3389/fphar.2022.891943 |
2022 |
* |
|
Designing, structural determination, and antibacterial activity of injectable ciprofloxacin-loaded gelatin-sodium carboxymethyl cellulose composite nanogels against Staphylococcus aureus. |
Liu J, Song W, Algharib SA, Luo W, Chen W |
Curr Drug Deliv |
10.2174/1567201819666220513121219 |
2022 |
* |
|
Synthesis and Antibacterial Activity Studies of the Conjugates of Curcumin with closo-Dodecaborate and Cobalt Bis(Dicarbollide) Boron Clusters. |
Druzina AA, Grammatikova NE, Zhidkova OB, Nekrasova NA, Dudarova NV, Kosenko ID, Grin MA, Bregadze VI |
Molecules |
10.3390/molecules27092920 |
2022 |
* |
|
Comparative Analysis of the Antimicrobial Activity of Essential Oils and Their Formulated Microemulsions against Foodborne Pathogens and Spoilage Bacteria. |
Campana R, Tiboni M, Maggi F, Cappellacci L, Cianfaglione K, Morshedloo MR, Frangipani E, Casettari L |
Antibiotics (Basel) |
10.3390/antibiotics11040447 |
2022 |
* |
|
Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit. |
Wang X, Wang R, Zhang ZS, Zhang GY, Jin Z, Shen R, Du D, Tang YZ |
Eur J Med Chem |
10.1016/j.ejmech.2022.114341 |
2022 |
* |
|
The effect of nickel ions on the susceptibility of bacteria to ciprofloxacin and ampicillin. |
Pavlic A, Gobin I, Begic G, Tota M, Abram M, Spalj S |
Folia Microbiol (Praha) |
10.1007/s12223-022-00960-x |
2022 |
* |
|
Anthraquinones from the Aerial Parts of Rubia cordifolia with Their NO Inhibitory and Antibacterial Activities. |
Luo H, Qin W, Zhang H, Ren FC, Fang WT, Kong QH, Yang L, Zhang JM, Fang CW, Hu JM, Liu SJ |
Molecules |
10.3390/molecules27051730 |
2022 |
* |
|
Dual-functional bioactive silk sericin for osteoblast responses and osteomyelitis treatment. |
Noosak C, Jantorn P, Meesane J, Voravuthikunchai S, Saeloh D |
PLoS One |
10.1371/journal.pone.0264795 |
2022 |
* |
|
Design, synthesis and antibacterial evaluation of pleuromutilin derivatives. |
Wu G, Zhu Z, Li J, Luo X, Zhu W, Liao G, Xia J, Zhang W, Pan W, Li T, Wu S |
Bioorg Med Chem |
10.1016/j.bmc.2022.116676 |
2022 |
* |
|
Natural Occurring Phenolic Derivatives from Mauritia flexuosa (Buriti) Stems and Their Potential Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus (MRSA). |
de Oliveira DM, de Oliveira DBC, Nunes YRF, de Almeida Alves TM, Kohlhoff M, Andrade AA, Cota BB |
Chem Biodivers |
10.1002/cbdv.202100788 |
2022 |
* |
|
RW-BP100-4D, a Promising Antimicrobial Candidate With Broad-Spectrum Bactericidal Activity. |
Tong X, Li J, Wei R, Gong L, Ji X, He T, Wang R |
Front Microbiol |
10.3389/fmicb.2021.815980 |
2022 |
* |
|
Antiadhesive, antibiofilm and dispersion activity of biosurfactants isolated from Bacillus amyloliquefaciens 3/22. |
Englerova K, Nemcova R, Bedlovicova Z, Stykova E |
Ceska Slov Farm |
10.5817/CSF2021-5-172 |
2021 |
* |
|
Effect of Essential Oils on Growth Inhibition, Biofilm Formation and Membrane Integrity of Escherichia coli and Staphylococcus aureus. |
Martinez A, Manrique-Moreno M, Klaiss-Luna MC, Stashenko E, Zafra G, Ortiz C |
Antibiotics (Basel) |
10.3390/antibiotics10121474 |
2021 |
* |
|
Ecofriendly Synthesis of Silver Nanoparticles Using Ananas comosus Fruit Peels: Anticancer and Antimicrobial Activities. |
Baran A, Keskin C, Baran MF, Huseynova I, Khalilov R, Eftekhari A, Irtegun-Kandemir S, Kavak DE |
Bioinorg Chem Appl |
10.1155/2021/2058149 |
2021 |
* |
|
Antiadhesive, antibiofilm and dispersion activity of biosurfactants isolated from Bacillus amyloliquefaciens 3/22. |
Englerova K, Nemcova R, Bedlovicova Z, Stykova E |
Ceska Slov Farm |
10.5817/CSF2021-5-172 |
2021 |
* |
|
Bacillus amyloliquefaciens-Derived Lipopeptide Biosurfactants Inhibit Biofilm Formation and Expression of Biofilm-Related Genes of Staphylococcus aureus. |
Englerova K, Bedlovicova Z, Nemcova R, Kiraly J, Madar M, Hajduckova V, Stykova E, Mucha R, Reiffova K |
Antibiotics (Basel) |
10.3390/antibiotics10101252 |
2021 |
* |
|
Provisional Use of CLSI-Approved Quality Control Strains for Antimicrobial Susceptibility Testing of Mycoplasma ('Mesomycoplasma') hyorhinis. |
Kabisch L, Schink AK, Kehrenberg C, Schwarz S |
Microorganisms |
10.3390/microorganisms9091829 |
2021 |
* |
|
New Unnatural Gallotannins: A Way toward Green Antioxidants, Antimicrobials and Antibiofilm Agents. |
Hricoviniova Z, Mascaretti S, Hricoviniova J, Cizek A, Jampilek J |
Antioxidants (Basel) |
10.3390/antiox10081288 |
2021 |
* |
|
Reduced Level of Tear Antimicrobial and Immunomodulatory Proteins as a Possible Reason for Higher Ocular Infections in Diabetic Patients. |
Kallo G, Varga AK, Szabo J, Emri M, Tozser J, Csutak A, Csosz E |
Pathogens |
10.3390/pathogens10070883 |
2021 |
* |
|
Natural Berberine-Hybridized Benzimidazoles as Novel Unique Bactericides against Staphylococcus aureus. |
Sun H, Ansari MF, Fang B, Zhou CH |
J Agric Food Chem |
10.1021/acs.jafc.1c02545 |
2021 |
* |
|
Rhodomyrtone Accumulates in Bacterial Cell Wall and Cell Membrane and Inhibits the Synthesis of Multiple Cellular Macromolecules in Epidemic Methicillin-Resistant Staphylococcus aureus. |
Nwabor OF, Leejae S, Voravuthikunchai SP |
Antibiotics (Basel) |
10.3390/antibiotics10050543 |
2021 |
* |
|
The Antibacterial Properties of 4, 8, 4', 8'-Tetramethoxy (1,1'-biphenanthrene) -2,7,2',7'-Tetrol from Fibrous Roots of Bletilla striata. |
Huang XJ, Xiong N, Chen BC, Luo F, Huang M, Ding ZS, Qian CD |
Indian J Microbiol |
10.1007/s12088-021-00932-8 |
2021 |
* |
|
Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity. |
Traczewski MM, Ambler JE, Schuch R |
J Clin Microbiol |
10.1128/JCM.03117-20 |
2021 |
* |
|
Development of a Broth Microdilution Method for Exebacase Susceptibility Testing. |
Oh JT, Ambler JE, Cassino C, Schuch R |
Antimicrob Agents Chemother |
10.1128/AAC.02587-20 |
2021 |
* |
|
Efficacy Prediction of Four Pharmaceutical Formulations for Intramammary Administration Containing Aloe vera (L.) Burm. f. Combined With Ceftiofur or Cloxacillin in Lactating Cows as an Alternative Therapy to Treat Mastitis Caused by Staphylococcus aureus. |
Forno-Bell N, Munoz MA, Chacon O, Pacha P, Iraguen D, Cornejo J, San Martin B |
Front Vet Sci |
10.3389/fvets.2021.572568 |
2021 |
* |
|
Design and evaluation of the antimicrobial properties of ackee seed extract silver nanoparticle film formulations. |
Odeniyi MA, Olusomoka E, Odeniyi OA, Adebayo-Tayo BC |
Polim Med |
10.17219/pim/130388 |
2020 |
* |
|
Design, Synthesis, and Biological Evaluation of Light-Activated Antibiotics. |
Shchelik IS, Tomio A, Gademann K |
ACS Infect Dis |
10.1021/acsinfecdis.1c00015 |
2021 |
* |
|
Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation. |
Pica M, Messere N, Felicetti T, Sabatini S, Pietrella D, Nocchetti M |
Materials (Basel) |
10.3390/ma14030670 |
2021 |
* |
|
Through quorum sensing, Pseudomonas aeruginosa resists noble metal-based nanomaterials toxicity. |
Li Z, Zhang Y, Huang D, Huang L, Zhang H, Li N, Wang M |
Environ Pollut |
10.1016/j.envpol.2020.116138 |
2020 |
* |
|
A Fluorinated Analogue of Marine Bisindole Alkaloid 2,2-Bis(6-bromo-1H-indol-3-yl)ethanamine as Potential Anti-Biofilm Agent and Antibiotic Adjuvant Against Staphylococcus aureus. |
Campana R, Mangiaterra G, Tiboni M, Frangipani E, Biavasco F, Lucarini S, Citterio B |
Pharmaceuticals (Basel) |
10.3390/ph13090210 |
2020 |
* |
|
Structural basis of quinolone derivatives, inhibition of type I and II topoisomerases and inquiry into the relevance of bioactivity in odd or even branches with molecular docking study. |
Wang Y, Xiao F, Jin G |
J Mol Struct |
10.1016/j.molstruc.2020.128869 |
2020 |
* |
|
[Antimicrobial effects of fentanyl and bupivacaine]. |
Kesici S, Demirci M, Kesici U |
Braz J Anesthesiol |
10.1016/j.bjan.2020.04.010 |
2020 |
* |
|
New marine-derived indolymethyl pyrazinoquinazoline alkaloids with promising antimicrobial profiles. |
Long S, Resende DISP, Palmeira A, Kijjoa A, Silva AMS, Tiritan ME, Pereira-Terra P, Freitas-Silva J, Barreiro S, Silva R, Remiao F, Pinto E, Martins da Costa P, Sousa E, Pinto MMM |
RSC Adv |
10.1039/d0ra05319h |
2020 |
* |
|
Characterization of Pediococcus acidilactici PFC69 and Lactococcus lactis PFC77 Bacteriocins and Their Antimicrobial Activities in Tarhana Fermentation. |
Kaya HI, Simsek O |
Microorganisms |
10.3390/microorganisms8071083 |
2020 |
* |
|
N-Nonyloxypentyl-l-Deoxynojirimycin Inhibits Growth, Biofilm Formation and Virulence Factors Expression of Staphylococcus aureus. |
De Gregorio E, Esposito A, Vollaro A, De Fenza M, D'Alonzo D, Migliaccio A, Iula VD, Zarrilli R, Guaragna A |
Antibiotics (Basel) |
10.3390/antibiotics9060362 |
2020 |
* |
|
Mutations in the MepRAB efflux system contribute to the in vitro development of tigecycline resistance in Staphylococcus aureus. |
Fang R, Sun Y, Dai W, Zheng X, Tian X, Zhang X, Wang C, Cao J, Zhou T |
J Glob Antimicrob Resist |
10.1016/j.jgar.2020.06.005 |
2020 |
* |
|
Application of median lethal concentration (LC50) of pathogenic microorganisms and their antigens in vaccine development. |
Saganuwan SA |
BMC Res Notes |
10.1186/s13104-020-05126-x |
2020 |
* |
|
Determination of Antimicrobial and Toxic Metal Removal Activities of Plant-Based Synthesized (Capsicum annuum L. Leaves), Ecofriendly, Gold Nanomaterials. |
Baran MF, Acay H, Keskin C |
Glob Chall |
10.1002/gch2.201900104 |
2020 |
* |
|
Antimicrobial Evaluation of Latex and TLC Fractions from the Leaves of Aloe adigratana Reynolds. |
Asmerom D, Hailu GS, Yimer EM, Bitew H, Kahsay G |
Evid Based Complement Alternat Med |
10.1155/2020/8312471 |
2020 |
* |
|
Dibasic Derivatives of Phenylcarbamic Acid as Prospective Antibacterial Agents Interacting with Cytoplasmic Membrane. |
Pospisilova S, Malik I, Bezouskova K, Kauerova T, Kollar P, Csollei J, Oravec M, Cizek A, Jampilek J |
Antibiotics (Basel) |
10.3390/antibiotics9020064 |
2020 |
* |
|
The roles of genes associated with regulation, transportation, and macrocyclization in desotamide biosynthesis in Streptomyces scopuliridis SCSIO ZJ46. |
Ding W, Dong Y, Ju J, Li Q |
Appl Microbiol Biotechnol |
10.1007/s00253-020-10414-4 |
2020 |
* |
|
Evaluation of Cumulative and Conditional Antibiotic Release from Vancomycin-Embedded Fibrin Sealant and Its Antibacterial Activity : An In Vitro Study. |
Shin DW, Sohn MJ, Cho CR, Koo HW, Yoon SW |
J Korean Neurosurg Soc |
10.3340/jkns.2019.0161 |
2019 |
* |
|
A new p-terphenyl derivative from the insect-derived fungus Aspergillus candidus Bdf-2 and the synergistic effects of terphenyllin. |
Shan T, Wang Y, Wang S, Xie Y, Cui Z, Wu C, Sun J, Wang J, Mao Z |
PeerJ |
10.7717/peerj.8221 |
2020 |
* |
|
Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm. |
Scriboni AB, Couto VM, Ribeiro LNM, Freires IA, Groppo FC, de Paula E, Franz-Montan M, Cogo-Muller K |
Front Pharmacol |
10.3389/fphar.2019.01401 |
2019 |
* |
|
Development, optimization, standardization, and validation of a simple in-house agar gradient method to determine minimum inhibitory concentration of vancomycin for Staphylococcus aureus. |
Rai S, Tandon M, Singh NP, Manchanda V, Kaur IR |
J Lab Physicians |
10.4103/JLP.JLP_11_19 |
2019 |
* |
|
Inhibitory effect of probiotic yeast Saccharomyces cerevisiae on biofilm formation and expression of alpha-hemolysin and enterotoxin A genes of Staphylococcus aureus. |
Saidi N, Owlia P, Marashi SMA, Saderi H |
Iran J Microbiol |
|
2019 |
* |
|
Antibacterial oral sprays from kaffir lime (Citrus hystrix DC.) fruit peel oil and leaf oil and their activities against respiratory tract pathogens. |
Srifuengfung S, Bunyapraphatsara N, Satitpatipan V, Tribuddharat C, Junyaprasert VB, Tungrugsasut W, Srisukh V |
J Tradit Complement Med |
10.1016/j.jtcme.2019.09.003 |
2019 |
* |
|
Microwaves increase the effectiveness of systemic antibiotic treatment in acute bone infection: experimental study in a rat model. |
Qi XY, Qiu XS, Jiang JY, Chen YX, Tang LM, Shi HF |
J Orthop Surg Res |
10.1186/s13018-019-1342-3 |
2019 |
* |
|
A Comparison of Bacterial Adhesion and Biofilm Formation on Commonly Used Orthopaedic Metal Implant Materials: An In vitro Study. |
Malhotra R, Dhawan B, Garg B, Shankar V, Nag TC |
Indian J Orthop |
10.4103/ortho.IJOrtho_66_18 |
2019 |
* |
|
Structure Elucidation and Antimicrobial Activities of Secondary Metabolites from the Flowery Parts of Verbascum mucronatum Lam. |
Kahraman C, Tatli II, Kart D, Ekizoglu M, Akdemir ZS |
Turk J Pharm Sci |
10.4274/tjps.50479 |
2018 |
* |
|
Sarconesin: Sarconesiopsis magellanica Blowfly Larval Excretions and Secretions With Antibacterial Properties. |
Diaz-Roa A, Patarroyo MA, Bello FJ, Da Silva PI Jr |
Front Microbiol |
10.3389/fmicb.2018.02249 |
2018 |
* |
|
Antimicrobial and Cytotoxicity Effects of Synthesized Silver Nanoparticles from Punica granatum Peel Extract. |
Devanesan S, AlSalhi MS, Balaji RV, Ranjitsingh AJA, Ahamed A, Alfuraydi AA, AlQahtani FY, Aleanizy FS, Othman AH |
Nanoscale Res Lett |
10.1186/s11671-018-2731-y |
2018 |
* |
|
Identification of 4-isopropyl-thiotropolone as a novel anti-microbial: regioselective synthesis, NMR characterization, and biological evaluation. |
Elagawany M, Hegazy L, Cao F, Donlin MJ, Rath N, Tavis J, Elgendy B |
RSC Adv |
10.1039/c8ra06297h |
2018 |
* |
|
Combination of Cloxacillin and Essential Oil of Melaleuca armillaris as an Alternative Against Staphylococcus aureus. |
Buldain D, Buchamer AV, Marchetti ML, Aliverti F, Bandoni A, Mestorino N |
Front Vet Sci |
10.3389/fvets.2018.00177 |
2018 |
* |
|
Efficient Exploitation of Multiple Novel Bacteriocins by Combination of Complete Genome and Peptidome. |
Yi L, Luo L, Lu X |
Front Microbiol |
10.3389/fmicb.2018.01567 |
2018 |
* |
|
The Bioactivity and Photocatalytic Properties of Titania Nanotube Coatings Produced with the Use of the Low-Potential Anodization of Ti6Al4V Alloy Surface. |
Radtke A, Topolski A, Jedrzejewski T, Kozak W, Sadowska B, Wieckowska-Szakiel M, Szubka M, Talik E, Pleth Nielsen L, Piszczek P |
Nanomaterials (Basel) |
10.3390/nano7080197 |
2017 |
* |
|
Biocompatibility of Titania Nanotube Coatings Enriched with Silver Nanograins by Chemical Vapor Deposition. |
Piszczek P, Lewandowska Z, Radtke A, Jedrzejewski T, Kozak W, Sadowska B, Szubka M, Talik E, Fiori F |
Nanomaterials (Basel) |
10.3390/nano7090274 |
2017 |
* |
|
Antibacterial, Antitubercular and Antiviral Activity Evaluations of Some Arylidenehydrazide Derivatives Bearing Imidazo[2,1-b]thiazole Moiety. |
Ulusoy Guzeldemirci N, Karaman B, Kucukbasmaci O |
Turk J Pharm Sci |
10.4274/tjps.25743 |
2017 |
* |
|
Bactericidal Effect of Photodynamic Therapy, Alone or in Combination with Mupirocin or Linezolid, on Staphylococcus aureus. |
Perez-Laguna V, Perez-Artiaga L, Lampaya-Perez V, Garcia-Luque I, Ballesta S, Nonell S, Paz-Cristobal MP, Gilaberte Y, Rezusta A |
Front Microbiol |
10.3389/fmicb.2017.01002 |
2017 |
* |
|
Distinct growth and extractive methods of Acmellaoleracea (L.) R.K. Jansen rising different concentrations of spilanthol: An important bioactive compound in human dietary. |
Franca JV, Queiroz MSR, do Amaral BP, Simas NK, da Silva NCB, Leal ICR |
Food Res Int |
10.1016/j.foodres.2016.09.018 |
2016 |
* |
|
A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35. |
Barreto-Santamaria A, Curtidor H, Arevalo-Pinzon G, Herrera C, Suarez D, Perez WH, Patarroyo ME |
Front Microbiol |
10.3389/fmicb.2016.02006 |
2016 |
* |
|
Antimicrobial Activity and Phytochemical Screening of Sarcocolla Gum Resin. |
Ababutain IM |
Pak J Biol Sci |
10.3923/pjbs.2017.571.576 |
2017 |
* |
|
Antimicrobial activity of a novel furan fatty acid, 7,10-epoxyoctadeca-7,9-dienoic acid against methicillin-resistant Staphylococcus aureus. |
Dasagrandhi C, Ellamar JB, Kim YS, Kim HR |
Food Sci Biotechnol |
10.1007/s10068-016-0257-6 |
2016 |
* |
|
The Effect of Ferula assa-foetida L and Carum copticum Hydroalcoholic Extract on the Expression Levels of Staphylococcus aureus Genes Involved in Quorum Sensing. |
Jomehpour N, Eslami G, Khalili MB |
Jundishapur J Microbiol |
10.5812/jjm.33879 |
2016 |
* |
|
Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of novel quinoline bearing dihydropyridines. |
Nkosi SM, Anand K, Anandakumar S, Singh S, Chuturgoon AA, Gengan RM |
J Photochem Photobiol B |
10.1016/j.jphotobiol.2016.10.009 |
2016 |
* |
|
The Structure-Antimicrobial Activity Relationships of a Promising Class of the Compounds Containing the N-Arylpiperazine Scaffold. |
Malik I, Csollei J, Jampilek J, Stanzel L, Zadrazilova I, Hosek J, Pospisilova S, Cizek A, Coffey A, O'Mahony J |
Molecules |
10.3390/molecules21101274 |
2016 |
* |
|
Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity. |
Grace JL, Huang JX, Cheah SE, Truong NP, Cooper MA, Li J, Davis TP, Quinn JF, Velkov T, Whittaker MR |
RSC Adv |
10.1039/C5RA24361K |
2016 |
* |
|
Phenolic compounds, antioxidant, and antibacterial properties of pomace extracts from four Virginia-grown grape varieties. |
Xu Y, Burton S, Kim C, Sismour E |
Food Sci Nutr |
10.1002/fsn3.264 |
2015 |
* |
|
Prevention of perioperative vascular prosthetic infection with a novel triple antimicrobial-bonded arterial graft. |
Aboshady I, Raad I, Vela D, Hassan M, Aboshady Y, Safi HJ, Buja LM, Khalil KG |
J Vasc Surg |
10.1016/j.jvs.2015.09.061 |
2015 |
* |
|
In Vitro Evaluation of Antimicrobial Efficacy of Extracts Obtained from Raw and Fermented Wild Macrofungus, Lenzites quercina. |
Ogidi OC, Oyetayo VO, Akinyele BJ |
Int J Microbiol |
10.1155/2015/106308 |
2015 |
* |
|
Antibacterial, antifungal and antimycobacterial activities of some pyrazoline, hydrazone and chalcone derivatives. |
Evranos-Aksoz B, Onurdag FK, Ozgacar SO |
Z Naturforsch C J Biosci |
10.1515/znc-2014-4195 |
2015 |
* |
|
In vitro bactericidal activity of 4- and 5-chloro-2-hydroxy-N-[1-oxo-1-(phenylamino)alkan-2-yl]benzamides against MRSA. |
Zadrazilova I, Pospisilova S, Pauk K, Imramovsky A, Vinsova J, Cizek A, Jampilek J |
Biomed Res Int |
10.1155/2015/349534 |
2015 |
* |
|
Phytochemical and biological activities of Bituminaria bituminosa L. (Fabaceae). |
Azzouzi S, Zaabat N, Medjroubi K, Akkal S, Benlabed K, Smati F, Dijoux-Franca MG |
Asian Pac J Trop Med |
10.1016/S1995-7645(14)60278-9 |
2014 |
* |
|
The effects of oral antibiotics on infection prophylaxis in traumatic wounds. |
Erbil B, Ersoy G, Ozkutuk A, Akarca FK, Korkmaz T, Demir OF, Kiyan S |
Ulus Travma Acil Cerrahi Derg |
10.5505/tjtes.2014.63993 |
2014 |
* |
|
Right atrial pressure alterations during echocardiography-guided-catheterization predict tricuspid valvular impairment: a novel method for the creation of a rabbit model of Staphylococcus aureus endocarditis. |
Wang ML, Zhang Y, Fan M, Guo YJ, Ren WD, Luo EJ |
Cardiovasc Ultrasound |
10.1186/1476-7120-12-21 |
2014 |
* |
|
Herbal extracts in the treatment of Diabetic Foot Syndrome. |
Kustova T, Karpenyuk T, Goncharova A, Mamonov L, Ross S |
Cent Asian J Glob Health |
10.5195/cajgh.2013.86 |
2014 |
* |
|
Essential oils and herbal extracts as antimicrobial agents in cosmetic emulsion. |
Herman A, Herman AP, Domagalska BW, Mlynarczyk A |
Indian J Microbiol |
10.1007/s12088-012-0329-0 |
2012 |
* |
|
Activity of the antiseptic polyhexanide against meticillin-susceptible and meticillin-resistant Staphylococcus aureus. |
Fabry W, Reimer C, Azem T, Aepinus C, Kock HJ, Vahlensieck W |
J Glob Antimicrob Resist |
10.1016/j.jgar.2013.05.007 |
2013 |
* |
|
Comparative study on the antibacterial activity of some flavonoids and their sulfonic derivatives. |
Woznicka E, Kuzniar A, Nowak D, Nykiel E, Kopacz M, Gruszecka J, Golec K |
Acta Pol Pharm |
|
2013 |
* |
|
In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide. |
Masadeh MM, Mhaidat NM, Alzoubi KH, Hussein EI, Al-Trad EI |
Infect Drug Resist |
10.2147/IDR.S41501 |
2013 |
* |
|
[Comparison of antibacterial activities of Tobramycin inhalation solutions]. |
Pisarev VV |
Antibiot Khimioter |
|
2013 |
* |
|
A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection. |
Aboshady I, Raad I, Shah AS, Vela D, Dvorak T, Safi HJ, Buja LM, Khalil KG |
J Vasc Surg |
10.1016/j.jvs.2012.02.008 |
2012 |
* |
|
In vitro analysis of bacterial morphology by atomic force microscopy of low level laser therapy 660, 830 and 904 nm. |
de Sousa NT, Guirro RR, Santana HF, Silva CC |
Photomed Laser Surg |
10.1089/pho.2011.3160 |
2012 |
* |
|
Mupirocin calcium microencapsulation via spray drying: feed solvent influence on microparticle properties, stability and antimicrobial activity. |
Durrigl M, Kregar ML, Hafner A, Klaric MS, Filipovic-Grcic J |
Drug Dev Ind Pharm |
10.3109/03639045.2011.580350 |
2011 |
* |
|
Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats. |
Ozturan KE, Yucel I, Kocoglu E, Cakici H, Guven M |
J Orthop Res |
10.1002/jor.21159 |
2010 |
* |
|
Corneal deposit of ciprofloxacin after laser assisted subepithelial keratomileusis procedure: a case report. |
De Benedetti G, Brancaccio A |
J Ophthalmol |
10.1155/2010/296034 |
2010 |
* |
|
Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives. |
Zhang YB, Feng LS, You XF, Guo Q, Guo HY, Liu ML |
Arch Pharm (Weinheim) |
10.1002/ardp.200900191 |
2010 |
* |
|
Laparoscopic diagnosis and treatment of aortic vascular prosthetic graft infections in a porcine model. |
Gao H, Lund L, Prag J, Sandermann J, Lindholt JS |
Eur J Vasc Endovasc Surg |
10.1016/j.ejvs.2007.07.005 |
2007 |
* |
|
Wound healing potential of Cassia fistula on infected albino rat model. |
Senthil Kumar M, Sripriya R, Vijaya Raghavan H, Sehgal PK |
J Surg Res |
10.1016/j.jss.2005.08.025 |
2005 |
* |
|
Synthesis, antibacterial and antifungal activities of electron-rich olefins derived benzimidazole compounds. |
Kucukbay H, Durmaz R, Orhan E, Gunal S |
Farmaco |
10.1016/S0014-827X(03)00068-5 |
2003 |
* |
|
[Reproducible model of a bacterial conjunctivitis]. |
Behrens-Baumann W, Begall T |
Ophthalmologica |
10.1159/000310366 |
1993 |
* |
|
An in vitro evaluation of HRE 664, a novel penem antibiotic. |
Fuchs PC, Barry AL, Jones RN, Aldridge KE |
Diagn Microbiol Infect Dis |
10.1016/0732-8893(88)90071-5 |
1988 |
* |
|
Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays. |
Nickolai DJ, Lammel CJ, Byford BA, Morris JH, Kaplan EB, Hadley WK, Brooks GF |
J Clin Microbiol |
10.1128/jcm.21.3.366-370.1985 |
1985 |
* |
|
Aminated Quinolinequinones as Privileged Scaffolds for Antibacterial Agents: Synthesis, In Vitro Evaluation, and Putative Mode of Action. |
Yildirim H, Bayrak N, Yildiz M, Mataraci-Kara E, Korkmaz S, Shilkar D, Jayaprakash V, TuYuN AF |
ACS Omega |
10.1021/acsomega.2c03193 |
2022 |
* |
|
Chitosan-Sodium Caseinate Composite Edible Film Incorporated with Probiotic Limosilactobacillus fermentum: Physical Properties, Viability, and Antibacterial Properties. |
Wai SN, How YH, Saleena LAK, Degraeve P, Oulahal N, Pui LP |
Foods |
10.3390/foods11223583 |
2022 |
* |
|
Synthesis of new benzimidazole derivatives containing 1,3,4-thiadiazole: their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies. |
Acar Cevik U, Isik A, Evren AE, Kapusiz O, Gul UD, Ozkay Y, Kaplancikli ZA |
SAR QSAR Environ Res |
10.1080/1062936X.2022.2149620 |
2022 |
* |
|
New Alkylpyridinium Anthraquinone, Isocoumarin, C-Glucosyl Resorcinol Derivative and Prenylated Pyranoxanthones from the Culture of a Marine Sponge-Associated Fungus, Aspergillus stellatus KUFA 2017. |
Machado FP, Rodrigues IC, Gales L, Pereira JA, Costa PM, Dethoup T, Mistry S, Silva AMS, Vasconcelos V, Kijjoa A |
Mar Drugs |
10.3390/md20110672 |
2022 |
* |
|
Antistaphylococcal Activities and ADME-Related Properties of Chlorinated Arylcarbamoylnaphthalenylcarbamates. |
Gonec T, Pindjakova D, Vrablova L, Strharsky T, Michnova H, Kauerova T, Kollar P, Oravec M, Jendrzejewska I, Cizek A, Jampilek J |
Pharmaceuticals (Basel) |
10.3390/ph15060715 |
2022 |
* |
|
Assessment of synergistic activity of rhamnolipid and linezolid against methicillin-resistant Staphylococcus aureus in-vitro and in-vivo with Galleria mellonella larvae model. |
Kaskatepe B, Ozturk S |
Microb Pathog |
10.1016/j.micpath.2022.105945 |
2022 |
* |
|
In vitro synergistic interaction between Melaleuca armillaris essential oil and erythromycin against Staphylococcus aureus isolated from dairy cows. |
Buldain D, Gortari Castillo L, Buchamer AV, Bandoni A, Marchetti L, Mestorino N |
Front Vet Sci |
10.3389/fvets.2022.1005616 |
2022 |
* |
|
Sterilization Procedures for Titanium Alloy Surfaces Leads to Higher Expression of Biofilm-Related Staphylococcus aureus Genes. |
Spiegel C, Nogler M, Coraca-Huber DC |
Antibiotics (Basel) |
10.3390/antibiotics11111647 |
2022 |
* |
|
Malfilanol C, a new sesquiterpenoid isolated from the deep-sea-derived Aspergillus puniceus A2 fungus. |
Niu S, Huang S, Wang J, He J, Chen M, Zhang G, Hong B |
Nat Prod Res |
10.1080/14786419.2022.2144299 |
2022 |
* |
|
Gallomyrtucommulones G and H, New Phloroglucinol Glycosides, from Bioactive Fractions of Myrtus communis against Staphylococcus Species. |
Guzzo F, Duran AG, Sanna C, Marasco R, Molfetta N, Buommino E, Fiorentino A, D'Abrosca B |
Molecules |
10.3390/molecules27207109 |
2022 |
* |
|
Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors Exhibit Bactericidal Activity against Planktonic and Biofilm Staphylococcus aureus In Vitro. |
Chen A, Dellos-Nolan S, Lu Y, West JS, Wozniak DJ, Mitton-Fry MJ |
Microbiol Spectr |
10.1128/spectrum.02056-22 |
2022 |
* |
|
Determination of Chemical Compounds and Investigation of Biological Properties of Matricaria chamomilla Essential Oils, Honey, and Their Mixture. |
Qasem A, Assaggaf H, Montesano D, Khalil Z, Al-Mijalli SH, Baaboua AE, El Omari N, El Menyiy N, Bakrim S, Sheikh RA, Alshahrani MM, Awadh AAA, Zengin G, Bouyahya A, Mrabti HN |
Molecules |
10.3390/molecules27185850 |
2022 |
* |
|
Effectiveness of mechanical cleaning, antibiotics, and induction heating on eradication of Staphylococcus aureus in mature biofilms. |
Pijls BG, Sanders IMJG, Kuijper EJ, Nelissen RGHH |
Bone Joint Res |
10.1302/2046-3758.119.BJR-2022-0010.R1 |
2022 |
* |
|
Antibiofilm Activity of Omega-3 Fatty Acids and Its Influence on the Expression of Biofilm Formation Genes on Staphylococcus aureus. |
Spiegel C, Steixner SJM, Coraca-Huber DC |
Antibiotics (Basel) |
10.3390/antibiotics11070932 |
2022 |
* |
|
Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups. |
Wang Q, Liu J, Zhou ZD, Zhou KX, Li F, Zhang QW, Wang SK, Wang W, Jin Z, Tang YZ |
J Enzyme Inhib Med Chem |
10.1080/14756366.2022.2104267 |
2022 |
* |
|
Novel Benzimidazole-Based Compounds as Antimicrobials: Synthesis, Molecular Docking, Molecular Dynamics and in silico ADME Profile Studies. |
Yesilcayir E, Celik I, Sen HT, Gurpinar SS, Eryilmaz M, Kilcigil G |
Acta Chim Slov |
10.17344/acsi.2021.7314 |
2022 |
* |